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SUMMARY 
( i i i ) 
SUMMARY 
Mortality and morbidity rates associated with tuberculous meningitis 
(TBM) are substantial. The average duration of the untreated 
disease from onset to death is about 17 days. The prognosis of 
TBM is known to correlate with the stage of the disease at the time 
of diagnosis and commencement of chemotherapy. Early diagnosis 
improves the chances of recovery without neurological sequelae. 
Early diagnosis is a problem because the presenting symptoms are 
non-specific and the onset of the disease is typically insidious. 
To date no single test is available that is totally reliable and 
specific for TBM. I have attempted to develop a reliable and 
easily applicable test for the diagnosis of TBM. In fulfilling 
this objective, the work undertaken may be divided into three 
major sections:-
1. Detection of soluble Mycobacterium tuberculosis antigens 
in the cerebrospinal fluid (CSF) of patients with TBM and 
in control groups by using Mycobacterium bovis BCG antigens. 
The technique used was that of inhibition enzyme-linked 
immunosorbent assay (ELISA). The principle of this 
technique is illustrated in Fig. 5. 
2. Detection of soluble M. tuberculosis antigens in the CSF 
of tuberculous and control groups of patients by using 
antibodies raised against M.bovis BCG. The technique 
used was that of the double antibody sandwich ELISA. 
An outline of this ELISA is given in Fig. 6. 
(iv) 
3. Correlation of chloride levels in the blood and CSF of 
patients with tuberculous and other forms of meningitis. 
It has been established that the SERUM/CSF ratio of 
bromide tends towards unity in patients with TBM because 
the permeability of the blood-brain barrier is impaired. 
Since both bromide and chloride are chemically similar 
(both being halides), it was thought that a similar 
pattern may exist for BLOOD/CSF chloride ratios; and 
this was investigated. 
The method used for the INHIBITION ELISA had to be standardized 
before the samples could be tested. This involved investigating 
the acceptability of various microtitre plates; determination of 
the optimal working dilutions for the coating solution and conjugate; 
and determination of optimal conditions for the various incubation 
periods, both in terms of time and temperature. A total of 70 
specimens was tested. These consisted of 25 normal CSF controls; 
25 pleural and ascitic fluid samples; 10 TBM samples, and 10 
bacterial meningitis CSF samples. It was found that a distinction 
existed between the absorbance values obtained from positive TBM 
CSF samples (Mean 0,658 + 0,043) and that from normal CSF samples 
(Mean 1,089 + 0,224). The mean absorbance of the culture-positive 
< 
bacterial CSF's also differed significantly from the other 2 groups 
(Tables VII; IX). 
Some overlap occurred amongst the absorbance values of bacterial 
culture positive CSF's (Range 0,975-0,879) and normal CSF's (Range 
1,486-0,934). The mean absorbance value for bacterial positive CSF 
(v) 
samples (0,920 _+ 0,029) differed significantly (p <0,01) from those 
of normal CSF (1,089 + 0,224) and TBM CSF's (0,658 + 0,043). The 
difference between the mean values obtained with tuberculous and 
non-tuberculous groups of pleural and ascitic fluid was also 
significant (p < 0,01). 
The method used for the DOUBLE ANTIBODY SANDWICH ELISA was that of 
Sada et al. (1983). Before the samples could be tested, the method 
had to be standardized and similar investigations to those for the 
INHIBITION ELISA were performed. In addition, antibodies raised 
against M.bovis BCG were conjugated to alkaline phosphatase since 
no commercial preparation was available. Unfortunately no distinction 
was recorded between negative and positive test specimens, even on 
repetition of the entire procedure. 
Measurement of chloride was done by a fully automated procedure using 
the BECKMAN ASTRA-8. A total of 149 samples were tested. Of these 
10 were tuberculous, 34 were viral, and the remainder were bacterial 
meningitis. No pattern was established that could differentiate TBM 
from viral or bacterial meningitis. The results obtained are tabulated 
in Table III and illustrated in Figures 9, 10, and 11. 
In summarizing, the use of the INHIBITION ELISA technique for the 
accurate diagnosis of TBM seems promising. However, its validity in the 
clinical situation will have to be assessed further and with greater 
numbers of specimens before it can be adopted as a diagnostic 




1. The ability and reliability of the'INHIBITION ELISA1 technique 
to detect mycobacterial antigens in pleural, ascitic, 
and cerebrospinal fluids. 
2. The accuracy and reproducibility of the double antibody 
sandwich ELISA in the detection of mycobacterial antigens 
in CSF of patients with tuberculous meningitis (TBM). 
3. Whether a correlation exists between blood and CSF chloride 
levels in patients with tuberculous and other forms of 
meningitis. 
(vii) 
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(a) Brief Historical Review of TBM 
Tuberculous meningitis (TBM) was first described a little more than 
two hundred years ago. Robert Whytt (1714-1788), a Scotsman, gave 
a typical clinical picture of the disease in his "OBSERVATIONS ON 
THE DROPSY IN THE BRAIN" (1768). Whytt attributed the aetiology of 
TBM to three factors; birth trauma, tumours, and suppression of 
. (26) urine. 
Sixty-five years later in 1833; the first accurate clinical study of 
TBM in children was published in the United States by William Wood 
(24) 
Gerhard (1809-1872). ; 
Another American, Ludwig Hektoen (1863-)was the first to publish work 
(25) on the vascular changes associated with TBM, in 1896. 
The tubercle bacillus, the causative agent of TB and TBM was first 
discovered in Germany by Dr Robert Koch (1843-1910). Koch achieved 
his discovery by the use of his own method of heat-fixing bacilli to 
glass slides and by the use of staining techniques developed by his 
students Ehrlich and Weigert. He demonstrated his findings on 
24 March 1882 at a meeting of the Berlin Physiological Society. 
Ehrlich used red fuchsin as a primary stain, decolourized with a 
mineral acid, and used methylene blue as a counterstain, thus showing 
red bacilli on a blue background as is the procedure today. Ziehl 
and Neelsen made minor modifications to the stain and acquired an 
undeserved eponym. 
Koch was able to grow a pure culture of the tubercle bacilli on 
meat infusion which he solidified with agar-agar. He described 
the pure colonies as being spindle-shaped, very fine and usually 
'S-shaped' 'v nowadays called serpentine cords. He also determined 
that the tubercle bacilli grew only in temperatures between 30°C and 
41° C. By administering the pure culture to experimental animals 
he proved conclusively that the tubercle bacilli were the cause of 
TB in these animals. 
One important practical application of the discovery of the tubercle 
bacilli was diagnostic. Isolating the bacilli from sputum and other 
clinical specimens was a certain method of diagnosis of all tuberculous 
processes. 
The diagnosis of TBM in the living was impossible at this stage without 
cerebrospinal fluid (CSF) samples. Many unsuccessful attempts were 
made to remove CSF. In 1891 Henry Quincke (1842-1922) described the 
(24) 
technique of lumbar puncture. 
1891 was also the year in which Koch made a discovery which was the 
basis of one of the most valuable diagnostic investigations in all 
tuberculous processes, the Tuberculin Test. He showed that a local 
inflammatory reaction could be elicited by the subcutaneous injection 
of a 'glycerine extract of a pure cultivation of the tubercle bacilli' 
in tuberculous patients. 
3 
In 1907 Von Pirquet (1874-1929) postulated the existence of sub-
clinical tuberculosis after finding that 80% of healthy 10 year-
olds in Vienna were tuberculin-positive. His suspicions were 
confirmed by Ghon's post-mortem studies undertaken between 1908 
and 1912. In 1908 Mantoux evolved the intradermal tuberculin 
test which is in use today to assess the status of tuberculosis 
in an individual. 
Since Koch's discovery of the tubercle bacillus more than a century 
ago, many attempts have been made to develop diagnostic tests for 
tuberculosis and TBM. These tests include isotope-studies and 
numerous biochemical and immunologic studies. Many prove helpful 
but no single test is confirmatory as yet. 
(b) Epidemiology of TBM 
TBM occurs in most cases as a complication of primary infection. 
It usually develops within 6 months of acquiring primary 
tuberculosis and occurs most commonly in infancy and early 
childhood. 
Tuberculosis is a socio-economically related disease. Its develop-
ment and spread is favoured by poor housing, overcrowding, malnutrition, 
in fact any physical or emotional stress. The prevalence of tuberculosis 
in the Western World has declined sharply with increasing industrializ-
ation, hence TBM is rare in such regions as compared to Third World 
countries. 
4 
In South Africa the distribution of tuberculosis amongst the races 
(3) 
is 82% Blacks; 15% Coloureds; 1,5% Asians and 1% Whites. 
Tuberculosis was unknown to the indigenous people of Southern Africa. 
It was brought to the sub-continent by White traders who had acquired 
resistance to the disease over many centuries of exposure to it. The 
Black population was very susceptible to tuberculosis and it is 
estimated that over 10 million Blacks are infected with the disease 
* (28) 
at present. 
Infected people do not necessarily develop overt disease. The 
infection remains dormant, e.g., in the lymph nodes, in the meninges, 
lung apices, vertebrae. In developed countries approximately 15% of 
infected people undergo reactivation of the inactive bacilli. In 
underdeveloped countries other negative factors such as measles, 
malnutrition and stress result in as many as 40% of cases becoming 
infectious. 
In a recent study of TBM in children under 15 years of age in the 
(14) . . 
Western Cape, the incidence per population group was as follows:-
White 0,2 *) 
Coloured 5,8 L per 100 000 
Black 25,7 J 
The number of cases of TBM was found to be higher in rural areas than 
in urban areas. 
Generally, mortality rates are high for TBM. The untreated patient 
survives on average only 17 days from onset of the disease. Of those 
who are diagnosed and treated, a high proportion suffer some form of 
neurological or intellectual damage. 
5 
In the Western Cape over a 2 year period (1979-1981) it was found 




from the disease. The national case fat ty rate for TBM for 
all ages in South Africa was 25,5% in 1980. 
(c) Clinical picture presented in TBM 
TBM manifests itself in innumerable ways. The conventional picture of 
fever, headache, vomiting, photophobia, neck stiffness, and impairment 
(43) 
of consciousness is rarely seen at the onset of the disease. 
Clinical features differ at different stages of the disease. 
(33) 
Kennedy and Fallon have staged the disease in the following manner: 
(i) Stage I - Patient fully conscious and rational with signs of 
meningeal irritation but with no focal neurological signs or evidence 
of hydrocephalus. Lassitude, apathy, anorexia, constipation and 
slight headaches may occur at this stage. 
(ii) Stage II - Patient mentally confused and/or focal neuro-
logical signs such as squints or hemiparesis present. Focal damage 
due to tuberculomas in the brain or cord sometimes causes fits and 
strokes. Meningeal inflammation may cause adhesions and infarctions 
and hence fits, impairment of consciousness or cranial nerve palsies 
may occur. 
(iii) Stage III - Patient mentally inaccessible owing to the 
depth of stupor or delirium and/or complete hemiplegia or paraplegia 
6 
or other major neurological abnormalities present. Hydrocephalus 
with drowsiness, coma and moderate papilloedema may occur at this 
stage. 
Diagnosis of TBM may not be made on the basis of clinical presentations 
alone; these have to be viewed in conjunction with laboratory findings. 
Early diagnosis is essential because the stage of the disease at which 
diagnosis is made is proportional to the outcome. The earlier the 
diagnosis, the less severe the mental and physical sequelae. 
(d) Conventional diagnostic criteria for TBM 
Conventionally the following criteria are used for the establishment 
of a diagnosis of TBM: 
(i) three of the following: 
(a) CSF pleocytosis and protein level > 0,6 g/£ 
(b) evidence of tuberculosis, such as chest radiographic 
appearances, sputum or gastric washings positive on 
M.tuberculosis culture, or a positive tuberculin 
skin test. 
(c) CSF culture positive, bromide partition ratio < 1,6. 
(in a study of the bromide partition ratio at King 
(11) 
Edward VIII Hospital, Durban, Coovadia, Y.M. et al 
found this test to be both reliable and accurate./ 
or CSF adenosine deaminase activity (ADA) > 5 U/£; 
and 
(d) Clinical course consistent with TBM; or 
(ii) autopsy findings indicating TBM. 
7 
TBM is often difficult to distinguish from other causes of meningitis, 
therefore I will give a brief indication of diagnostic procedures for 
these. 
(e) Diagnostic criteria for Bacterial meningitis 
Lumbar puncture is the major definitive investigation in bacterial 
meningitis. The following criteria are used in the diagnosis of 
bacterial meningitis: 
(1) CSF cloudy or purulent with pleocytosis; CSF/blood glucose 
ratio reduced (usually < 0,4, g/£); and elevated protein 
content (usually 0,5-3,0 g/£). 
(2) evidence of bacteria in CSF from Gram stain or positive CSF 
or blood culture. 
(3) identification of causative organism by detecting the presence 
of bacterial antigen in CSF with latex agglutination or counter-
immuno-electrophoresis (CIE) . 
(4) clinical course consistent with bacterial meningitis; or 
(5) autopsy findings indicating bacterial meningitis. 
(f) Diagnostic criteria for Viral (Aseptic) meningitis 
Diagnosis is usually based on the CSF characteristics (Table I) including 
normal glucose and failure to grow bacteria on culture. Predominant 
clinical symptoms include fever, headache, vomiting, malaise, and stiff 
neck and back. A bromide partition ratio > 1,6 is indicative of viral 
meningitis. A precise diagnosis requires either isolation of the virus 
by tissue culture; or the use of paired serums to document a rise in 
•u J- (2) antibodies. 
TABLE I : CHARACTERISTICS OF CSF IN INFECTIONS OF THE CENTRAL NERVOUS SYSTEM (after Dawood, A.A.(14)). 
Normal Pyogenic Aseptic Tuberculous 
Appearance 
Cells (mm3) 
Protein level (g/1) 





0,15 - 0,4 
2,2 - 3,3 
Turbid 
5 - 2000 
Neutrophils 
mainly 




5 - 500 
Lymphocytes 




5 - 1000 
Lymphocytes 





II. INVESTIGATIONS AVAILABLE 
FOR DIAGNOSIS OF TBM 
(a) Microscopy 
Microscopic examination of spinal fluid is necessary in all cases of 
suspected meningitis. This examination includes a cell count, Gram 
stain, and differential staining techniques. 
(i) Cell Count - This is usually the first investigation 
performed since delays may cause inaccuracies as well 
as clot formation. An aliquot of CSF is usually diluted 
in a 9:1 ratio with counting fluid (crystal violet, 
azur A. McNeil or malachite green). Counting is done by 
using a Neubauer Counting Chamber. 
In most cases of TBM the cell count is between 100 and 
(2) 
600/cu mm and is principally mononuclear. However, 
(43) 
Parsons reports that a polymorphonuclear leucocytosis 
3 
of 15 000 to 23 000/mm is compatible with a diagnosis of 
TBM. Non-conforming results are frequent in TBM - some 
cell counts may only be slightly raised and positive 
cultures have been obtained from CSF samples with virtually 
,, , (2;23) no cellular count. 
(ii) Gram stain. This is performed routinely on CSF's of all 
suspected cases of meningitis. In cases of TBM no 
organisms are generally detected in a Gram stain. 
(iii) Staining techniques used in the detection of .V. Tuberculosis 
Mycobacteria are acid-fast, alcohol-fast, non-motile, non 
spore-forming bacilli. M. tuberculosis organisms are found 
10 
as slender rods (0,3 - 0,6 x 0,5 - 4,0 pm) that occur 
singly, in small clusters, or in "threads" (in culture). 
Staining may be homogenous or granular; the latter 
resulting in a banded or beaded appearance. 
(a) Ordinary light microscopy - Ziehl Neelsen or Kinyoun's 
Acid Fast stain. The acid-fast stain is a differential 
stain that measures the resistance of a stained cell to 
decolourization by acids. The property of acid-fastness 
in mycobacteria is correlated with their high lipid content. 
Initial staining is done with hot carbol fuchsin, the bacteria 
are then decolorized with acid-alcohol and counter-stained 
with methylene blue. Mycobacteria resist decolourization and 
thus stain red. Non acid-fast organisms stain blue. 
(b) Fluorescence microscopy - under ultra violet light (Auramine 
Rhodamine stain) or under blue light (auramine-0-stain). 
The auramine-rhodamine stain has proved more accurate than 
(43) the Ziehl-Neelsen method. 
(c) Oil immersion lens (900-1 000 x) - against a blue or green 
background (conventional acid-fast stains). 
The most important finding in TBM is of Mycobacterium tuberculosis in 
the CSF but the frequency with which organisms are seen varies from 
unit to unit. Some have success rates of 85-100% while others report 
that it is with difficulty that the organisms are seen or cultured 
• • (43) 
even when it is known that they are present. In Durban it is 
exceedingly uncommon to find M. tuberculosis in CSF specimens from 
patients known to have TBM by other criteria. 
11 
(b) Culture Studies 
Primary mycobacterial isolation medium includes various egg yolk or 
whole egg preparations containing malachite green as an inhibitory 
agent; at least one selective medium of either egg or agar base 
(containing various inhibitory agents) must also be employed. Growth 
is very slow. Inoculated culture media is usually incubated at 35-37°C 
for 8 weeks with weekly inspection for growth. Most strains of 
M. tuberculosis appear within 4 weeks but they may not be visible for 
8 weeks or more if they originated from patients treated with anti-
tuberculous agents (Kennedy et al, 1979) . 
Cultures on Lowenstein-Jensen fresh whole egg medium show raised, 
rough, wrinkled, buff-coloured granular growth after 3 to 8 weeks 
of incubation at 37°C. PLATE 1 shows tube culture of M. tuberculosis 
in Lowenstein-Jensen medium. 
Strains of M. tuberculosis are clearly identifiable by their lack of 
pigment, failure to grow at 25°C, and sensitivity to p-nitrobenzoic 
., (53) 
acid. 
(c) Biochemical Studies 
(i) CSF Adenosine Deaminase Activity 
Adenosine Deaminase (ADA) was first discovered in 1939. ' * a 
found to be widely distributed in animal tissues including the blood of 
normal humans and other mammals. ADA specifically reacts with adenosine 
and several adenine nucleoside analogues. It has been found that raised 
ADA levels occur in serum, CSF, and cell lysates in a variety of diseases 
12 
PLATE 1 : Tube culture of M.tuberculosis 
in Lowenstein-Jensen medium 
i 
13 
such as typhoid, malignant tumours and viral hepatitis. **S*9;.J5.J 
(45) 
The ADA level in tuberculous pleural effusion is markedly raised. 
CSF ADA levels corresponding to different types of meningitis are not 
(44) well defined. Piras and Gakis, in a study of 42 patients found 
that all those with TBM had ADA levels above 8U/£j all those with 
viral meningitis had levels below 4 U/£ } and that most patients with 
acute bacterial meningitis had levels below 5U/£ except two patients 
with levels above 8U/£. Pirakis and Gakis measured ADA activity 
repeatedly in 5 patients with TBM. They found that the ADA levels 
increased 15-30 days after onset of the illness and fell progressively 
as the patient recovered. 
In a study of 58 children in whom the final diagnosis was known, 
Mann et al, in 1982 found that 24 of 33 patients with TBM had 
ADA levels above 5U/2.. Overall, the ADA levels were found to have 
an accuracy of 86%. Whilst not specific for TBM, CSF ADA levels 
provide valuable evidence for or against a diagnosis of TBM and 
should be viewed in the light of clinical and laboratory findings. 
The method presently being used to measure ADA activity is based on 
(29) 
that of Giusti and is a sensitive colorimetric method. ADA breaks 
down adenosine to form inosine and ammonia which in turn combines with 
sodium hypochlorite to produce a dense blue colour which is read 
spectrophotometrically at 620 nm. 
ADA 
Adenosine + H„0 > Inosine + ammonia 
(f ^ — >0^=/ 
catalysl 
dense blue colour. 
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(ii) Gas Chromatography Studies 
(4) 
In 1977 Brooks et al, using gas chromatographs equipped with 
frequency-pulsed modulated electron capture (FPEC) detectors, 
detected the presence of a compound with amine characteristics 
in the CSF of 12 patients with acute untreated TBM. The compound 
was NOT found in the CSF chromatograph patterns of patients with 
aseptic and cryptococcal meningitis. In patients with TBM the 
compound disappeared with effective therapy. Mass spectrometry 
analysis identified the compound as being 3-(2'-ketohexyl) indoline. 
Brooks et al, found this to be valuable for differentiating between 
tuberculous, cryptococcal, and aseptic meningitis. 
Further studies by Brooks et al, published in 1980 describe gas 
chromatography studies on 260 CSF samples from both tuberculous and 
non-tuberculous patients from Egypt, USA, Canada and South America. 
It was found that only 60% of the Egyptian tuberculous patients and 
none of the culture positive American specimens contained 3-(2'-
ketohexyl) indoline. It was found, however, that the carboxylic acid 
and hydroxy acid chromatograph profiles obtained from the American 
and Egyptian tuberculous CSF samples were similar. Together with 
clinical data, these acid profiles may be used effectively in the 
diagnosis of TBM, even in the absence of 3-(2'-ketohexyl) indoline. 
(39) 
In 1983 Mardh et al, reported the presence of tuberculostearic 
acid in the CSF of a patient with TBM. The CSF sample was taken 
before antibiotic treatment was instituted. Gas chromatography/ 
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Mass spectrometry techniques were used to detect the 
tuberculostearic acid. This technique is very sensitive and 
can detect picogram amounts of the acid. The sample of CSF 
analysed contained 50 picograms of tuberculostearic acid, i.e., 
a concentration of approximately 3 ng/mg CSF. Figure 1 shows 
the mass chromatogram obtained. Tuberculostearic acid is a 
characteristic constituent of mycobacteria and the demonstration 
of its presence by gas chromatography is useful as a diagnostic 
marker for TBM. 
(iii) CSF Lactate and Lactate dehydrogenase levels: 
enzymatic measurement 
As early as 1938 it was reported that CSF lactate and lactate 
dehydrogenase (LD) levels were reported to be raised in cases of 
TBM (Donald and Malan) (19) Increases in lactate concentration 
(32;40) 
have also been recorded in patients with bacterial meningitis, 
cerebral or subarachnoid haemorrhage- and cerebral infarction 
The cause of increased lactate levels is not certain but is thought 
to be a result of decreased cerebral blood flow and hence decreased 
oxygen uptake in the brain. This in turn would result in the anaerobic 
glycolysis of cerebral tissue which involves both lactate and LD. 








i . T'u.r, T_T i p f o t - o n<=»H\rrl r n c r p n ^ <5P R p . a c t i OT1 
NADH + H 
16 
Scan number 
Fig. 1 : Mass chromatogram depicting tuberculostearic 
acid in CSF of patient with TBM 
(after Mardh P.A. et al; 1983) 
Donald and Malan in 1985 reported their investigation of CSF 
lactate and LD levels as a means of distinguishing TBM from aseptic 
meningitis. Lactate concentration was assayed enzymatically with a 
Boehringer-Mannheim kit and CSF LD was determined by an optimized 
standard method (Boehringer Mannheim). The results obtained from 
a study of 39 patients with TBM showed that although CSF lactate 
and LD levels were often raised in TBM, this was not always the case. 
In the case of CSF lactate levels, the sensitivity of the test was 
only 69% in detecting TBM. In the case of LD levels, the sensitivity 
was only 55%. 
Neither test was found to hold any marked advantages over conventional 
biochemical analysis of CSF in the differentiation of TBM from viral 
meningitis. 
(iv) Tryptophan Colour Test 
This is a quantitative test for all a-amino-acids, including 
tryptophan. It entails the oxidative decarboxylation of the amino 
acid by ninhydrin to produce an aldehyde, carbon dioxide, and ammonia. 
The reduced ninhydrin then reacts with the liberated ammonia to form 
a blue complex which maximally absorbs light of wavelength 570 nm. 
On the basis of reports that the colour test for tryptophan was 
beneficial in diagnosing TBM, this test was evaluated in 1980 by 
Brooks et al. They reported that many culture positive 
M. tuberculosis specimens gave no colour. In addition a positive 
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colour test was obtained in CSF samples from patients with herpes, 
syphilis and granulomatous meningitis. In view of both the false 
positive and false negative results obtained and also the fact that 
no free tryptophan was detected by gas chromatography analysis, it 
was concluded that this test was of no diagnostic value for TBM. 
(d) Radio Isotope Studies 
Walter, in 1929 showed that the blood-brain barrier was damaged in 
• • (37) tuberculous meningitis. He was the first to measure the 
permeability of the blood-brain barrier by estimating the partition-
ing of administered bromide between blood and CSF. This was 
expressed as the SERUM/CSF BROMIDE RATIO. Walter observed that 
after a loading dose of bromide, the relative concentration of 
bromide in blood and CSF was between 2,9-3,5 (mean 3,1) in normal 
subjects. In cases of TBM this ratio was found to decrease because 
the permeability of the blood-brain barrier increased and the 
relative concentrations of bromide in blood and CSF thus tended 













Fig. 3 : The CSF/serum bromide ratio in patients with 
viral and tuberculous meningitis 
(after Parsons, M. (1979)) 
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Walter used the gold chloride colorimetric method for his bromide 
estimations, which became known as the Bromide Partition Test (BPT). 
In the 1940's and 1950's several groups of workers^41,49'50 modified 
(50) 
and assessed the bromide partition test. Taylor et al found that 
the bromide ratio estimated by the gold chloride method was too high 
as substances other than bromide in the serum were reacting with gold-
chloride. He then introduced the iodometric titration method for 
bromide estimation. 
(56) 
Taylor et al in 1954 confirmed the value of the BPT in the 
differential diagnosis of meningitis by showing that in the great 
majority of tuberculous cases the ratio was < 1,6, whereas in cases 
of 'non-purulent1, non-tuberculous meningitis, higher values resulted. 
The chemical method of bromide estimation proved too difficult 
technically to be of practical value. In 1960 Crook et al, 
advocated the use of radioisotopes to estimate the bromide ratio. 
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The radioactive isotope used was Br which has a half-life of 35,4 
hours and emits beta rays of maximum energy 0,4 meV and gamma rays 
with energies in the range 0,55-1,48 meV. A scintillation counter 
was used to measure the radioactivity in 48 hour blood and CSF 
samples after the administration of sodium bromide. 
Using the radioactive bromide partition test Crook et al clearly 




In 1972 Mandal et al, confirmed that the radioactive bromide 
partition test was a valuable procedure for the early diagnosis of 
TBM. Using the figure of 1,6 as the critical bromide ratio value 
they found the test to be 100% accurate in both tuberculous and non-
tuberculous adult groups. 
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In a study of 91 children on whom the radioactive bromide ( Br) 
partition test was performed, Wiggelinkhuizen and Mann (1980) found 
the test to be 92% accurate. They found that a low bromide partition 
ratio was not specific for TBM; purulent meningitis, neurosyphilis, 
spinal block, congenital hypothyroidism,congenital encephalo-
opthalmic dysplasia and multiple sclerosis all resulted in ratios 
similar to those found in TBM. The test was, however, found to be 
particularly useful in distinguishing early TBM from viral meningitis. 
(•}«) 
In 1982 Mann et al, confirmed that the bromide partition test (BPT) 
provided valuable evidence for or against the diagnosis of TBM. In a 
comparison between the BPT and CSF ADA measurements (discussed 
previously under Radio-Isotope Studies and Biochemical studies) they 
found that the BPT proved more accurate than CSF ADA measurements 
(93% as compared to 86%). 
In summary it may be said that the bromide partition test is not 
specific for TBM and the results should be interpreted in the light 
of all clinical and laboratory findings. A ratio of below 1,6 is 
strongly supportive of a diagnosis of TBM and one above it is 
against the diagnosis. Studies are presently being done concerning 
the replacement of bromide by technetium and this promises to make 
. . (43) 
the test more sensitive than at present. 
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(e) Immunological Studies 
(i) Precipitin Test 
The precipitin test for mycobacterial antigens was developed in 1929 
(18} 
by Doan. The antibody he used was rabbit antisera to 'phosphatide' 
(a plasma membrane antigen from M. tuberculosis). Doan tested blood 
sera, spinal fluids, pleural effusions, ascitic fluids and joint 
fluids from tuberculous infants. Only the CSF of one of 12 infants 
with TBM failed to give a positive precipitin reaction with the anti-
phosphatide rabbit sera. Only 1 false-positive test was recorded in 
sixteen control spinal fluids. The blood sera of all tuberculous 
infants tested was strongly positive. However, the blood sera from 
9 cases of Hodgkin's disease also gave positive precipitin titres. 
(ii) Enumeration of T-cells in CSF by E-rosette formation 
The mature T lymphocytes of humans carry receptors which bind to 
determinants on the surface of sheep red blood cells (SRBC). When 
mixed with SRBC, each T-cell binds a cluster of SRBC to its surface, 
forming a rosette (Figure 4). Such 'E' (erythrocyte)-rosettes 
provide a convenient way to count and identify human T--cells. 
(21) 
El-Naggar and Higashi reported in 1981 that they had enumerated 
the number of lymphocytes in the blood and CSF of tuberculous patients 
by using E-rosettes. They found that the proportion of T-cells in the 
CSF was greater than that in the peripheral blood. The number of T-cells 
in the blood of tuberculous patients was significantly lower than that 
in normal people. However, the number of T-cells in the CSF of normal 
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people was found to be no different from that in tuberculous patients, 
No reliable way was found to assay CSF T-cell functional responses to 
mycobacterial antigens. 
Until T-cell enumeration in bacterial and viral meningitis is under-
taken, little value may be placed in the ratio of CSF to blood T-cell 
numbers as a diagnostic marker in patients with TBM. 
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Fig. 4 : E-Rosette formation-mechanism 
(iii) Enzyme-linked Immunosorbent Assay (ELISA) 
(1) Detection of specific antibodies 
Hernandez et al, have reported 100% sensitivity and no false-
positive reactions whilst using an indirect ELISA to diagnose TBM. 
Patients with TBM undergo a vigorous humoral immune response in the 
CNS (central nervous system). This results in the production of 
oligoclonal antibodies against Mycobacterium tuberculosis which also 
react against Mycobacterium bovis BCG. These antibodies are secreted 
into the CSF. 
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In the ELISA of Hernandez et al, BCG antigen was covalently attached 
to plastic discs. CSF samples from patients with tuberculous, pyogenic 
and viral meningitis and from a control group were assayed for 
immunoglobulin G (igG) and immunoglobulin M (IgM) activity against 
M.bovis BCG. No overlapping of values from positive and negative 
samples occurred and there was a marked difference in antibody 
activity between samples from TBM and the other groups studied. 
This assay may prove useful in the early diagnosis of TBM. 
(32) 
Kalish et al, have shown the ability of the ELISA method to 
measure IgG activity against protein-purified derivative (PPD) from 
M. tuberculosis in the CSF of patients with TBM. They found that IgG 
could be detected in the CSF of all tuberculous patients but not in 
those of controls. The result of serial studies showed that IgG 
activity against PPD decreased as the recovery of the patients 
progressed. Since only three patients with tuberculous meningitis 
were studied, many more patients will have to be evaluated before 
this ELISA for IgG against PPD can be used as a means of early 
diagnosis of patients with suspected TBM. 
(2) Detection of mycobacterial antigens 
A double antibody sandwich ELISA to detect mycobacterial antigens in 
(47) 
the CSF of patients with TBM has been developed by Sada et al. 
Since Mycobacterium bovis BCG and Mycobacterium tuberculosis were 
(6) 
found to have the same surface antigens, antibody against 
M.bovis BCG was used in this assay. The specificity of the test 
proved to be 95% and the sensitivity was 81,25%. The authors suggest 
(13) 
the use of antibodies directed against antigen 5 and 6 of M.tuberculosis 
which are specific for this bacillus as a means of improving the test. 
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(iv) Latex Particle Agglutination 
( 36) 
Krambovitis and co-workers " have used latex particle agglutination 
(LPA) for the detection of M. tuberculosis plasma membrane antigen as 
a means of detecting M. tuberculosis in CSF. Rabbit immunoglobulin 
raised against the plasma membrane antigen was purified and used to 
passively sensitize latex particles. These particles were mixed 
with the CSF sample and antigen was indicated if agglutination 
occurred within three minutes. A positive result was obtained in 
the initial sample from 17 of 18 children with TBM. Only one false-
positive was recorded in the 134 controls tested. The authors state 
that the LPA test is a very simple and rapid technique requiring 
small quantities of CSF and is suitable for use in developing 
countries. Before this test can be adopted for clinical use a high 
degree of specificity and sensitivity will have to be obtained in 
trials on a larger group of patients. 
(v) C reactive protein measurement by Radioimmunoassay 
C reactive protein measurement in sera is measured serially by radio-
immunoassay. It has been established that C reactive protein 
determinations in serum differentiate reliably between bacterial and 
. . (15) 
viral meningitis. De Beer et al, undertook an investigation to 
determine whether C reactive protein measurements in patients with 
TBM differed appreciably from those of patients with viral and 
bacterial meningitis. C reactive protein measurements were made in 
sera from 31 children with bacterial meningitis, 15 with TBM, and 28 
with viral meningitis. 
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It was found that C reactive protein measurements in patients with 
TBM were intermediate, lying between those of bacterial and viral 
meningitis. It was also found that C reactive protein concentrations 
fell rapidly after treatment began and became normal after 10 days. 
This occurred in all but two of the patients with TBM. This rapid 
decline in concentration after treatment is of diagnostic value for 
TBM. Although not conclusive, it remains a useful additional parameter 
in the diagnosis and management of tuberculous meningitis. 
(f) Currently-used method for diagnosis of TBM 
To date no single diagnostic test for TBM has proved to be totally 
confirmatory of the disease. Many of the techniques already 
discussed may prove helpful in the diagnosis of TBM if used in 
conjunction with the CSF laboratory profile and the clinical picture. 
Some of the following criteria are used currently for the establish-
ment of a diagnosis of TBM: 
(1) CSF pleocytosis and protein level > 0,6 g/2 
(2) evidence of tuberculosis such as chest radiographic 
appearances, sputum or gastric washings positive on 
M. tuberculosis culture 
(3) positive tuberculin skin test 
(4) CSF culture positive 
(5) bromide partition ratio < 1,6 
(6) CSF adenosine deaminase activity (ADA) > 5U/£ 
(7) CSF glucose content less than half that of simultaneously 
obtained blood 
(8) clinical course consistent with TBM 
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It must be stressed that 'non-conforming' bacteriological, cyto-
logical, biochemical and clinical data are frequently occurring in 
patients with TBM. The absence of any of the above-mentioned 
criteria should not be reason to dismiss the possible diagnosis 
of TBM in a patient. Diagnosis is strongly suspected when there is 
a past history of TB or of exposure to someone with it, or when 
demonstrable tuberculous foci are present elsewhere in the body. 
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1. Routine Studies on CSF 
Each sample of CSF was subjected to routine cytological and bio-
chemical tests, using standard techniques. These tests included 
measurement of chloride levels; total protein and globulin content; 
and glucose levels. In addition, direct smears, Gram stains and cell 
counts were made. If organisms were identified, identification was 
confirmed by culturing or by bacterial agglutination kits. If no 
organisms were visible and the CSF profile resembled that of TBM, 
then CSF culture for M. tuberculosis was undertaken. 
(a) Measurement of Glucose in CSF 
(Standard technique performed routinely in the laboratory using a 
fully automated instrument.) The instrument used was the BECKMAN 
ASTRA-8, Automated Stat/Routine Analyser. The method of measurement 
is based on an enzymatic reaction, the GLUCOSE OXIDASE REACTION. 
glucose 
oxidase 
+ H20 + 02 > COOH + H O 
R 
5-glucose g luconic 
ac id 
The oxygen consumed in the oxidation of glucose to gluconic acid is 
measured by an oxygen electrode. The rate of oxygen consumption is 
proportional to the initial glucose concentration in the sample. 
(b) Measurement of Globulin and Total Protein in CSF 
Both total protein and globulin measurements are made using a fully 
automated instrument, the BECKMAN ASTRA-8 Automated Stat/Routine 
I I I . METHODS 
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Analyser. The instrument simultaneously determines total protein 
(by the BIURET METHOD) and makes a direct spectrophotometric 
determination of globulin levels. This combination of determinations 
allows the calculation of CSF albumin by subtracting the globulin 
value from the total protein. 
Total globulin is measured by the reaction of the tryptophan residues 
of the globulin molecules with glyoxylic acid in a strongly acidic 
medium. The coloured product of the reaction absorbs strongly at 
550 nm. Globulin is recorded as negative; trace; one, two or three 
plus; depending on the density of the coloured product. 
The principle of total protein measurement involves the precipitation 
of protein by trichloroacetic acid. The degree of turbidity is 
measured and is related to the quantity of protein present. 
(c) Method for Cell Count in CSF 
(Standard technique using a light microscope and a NEUBAUER counting 
chamber). Since the number of blood cells found in CSF is generally 
very small, manual counting techniques were employed. 
(d) Measurement of CSF Chloride level 
Standard technique used. Fully automated procedure with BECKMAN 
ASTRA-8 Automated Stat/Routine Analyser. Method of measurement was 
colorimetric titration. Both electrode and cathode comprised of 
silver chloride. 
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(e) CSF Culture for M.tuberculosis 
A loopful of CSF is streaked on Lowenstein-Jensen (LJ) medium and 
incubated at 37°C for eight weeks. Smears are prepared from growth, 
if any, and stained by Ziehl-Neelsen's technique. 
2. Correlation of Blood and CSF Chloride levels 
(i) Patients 
Blood and CSF samples taken within about four hours of each other 
were collected from a total of 149 Black children admitted to King 
Edward VIII hospital during the six-month period February-August 1985. 
In addition, a detailed case-history and record of the clinical 
examination was made. Each sample was subjected to the following 
studies: 
(a) Routine cytological and biochemical tests were done on both 
the blood and CSF, using standard techniques. 
(b) Blood and CSF chloride measurements were made. 
(c) CSF was cultured for M. tuberculosis on LJ medium. 
(d) All patients were followed up as far as possible, to confirm 
or reject the initial diagnosis. 
For the establishment of a diagnosis of IBM, the following criteria 
were used: 
(a) CSF pleocytosis; predominantly lymphocytes (5-1000 cells per mm ) 
(b) protein level > 0,6 g/& 
(c) ancilliary evidence of tuberculosis such as chest radiographic 
appearances, sputum or gastric washings positive on 
M. tuberculosis culture, or a positive tuberculin skin test 
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(d) CSF culture positive, bromide partition ratio < 1,6; or 
CSF ADA > 5U/£ 
(e) Clinical course consistent with TBM 
(f) Autopsy findings indicating TBM. 
The diagnostic criteria for viral meningitis were: 
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(a) CSF characteristics - clear: 5-500 cells/mm , mainly 
lymphocytes; protein level of 0,5-1,0 g/£ 
(b) Normal CSF glucose level 
(c) Clinical picture consistent with viral meningitis 
(d) Bromide partition ratio > 1,6. 
The diagnostic criteria used for bacterial meningitis were: 
(a) CSF cloudy or purulent with pleocytosis; CSF/blood glucose 
ratio reduced (usually < 0,4 g/£); and elevated protein 
content (usually 0,5-3,0 g/I) 
(b) evidence of bacteria in CSF from Gram stain or positive 
CSF or blood culture 
(c) detection of bacterial antigens via latex agglutination or CIE. 
(d) clinical course consistent with bacterial meningitis. 
(e) autopsy findings indicating bacterial meningitis. 
(ii) Measurement of Chloride 
This procedure was fully automated. The mode of measurement was via 
colorimetric titration, using silver chloride for both the cathode and 
the anode. The instrument used was the BECKMAN ASTRA-8 AUTOMATED 
STAT/ROUTINE ANALYSER. Measurements were made in mmol/1. 
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3. Inhibition of BCG-anti-BCG reaction by M. tuberculosis 
antigen using ELISA 
The diagnosis of TBM on clinical grounds alone is very difficult. 
Many non-specific tests such as routine examination of CSF, bromide-
(37) . . . . (29) 
partition test, adenosine deaminase estimation available so 
far are not very useful. The low bacterial density of CSF from 
patients with TBM makes bacteriological diagnosis with smears and 
culturing very difficult especially in the Third World. It has been 
established that the neurological sequelae and fatalities associated 
with diagnosis of TBM at an advanced stage of the disease are severe 
compared to that in early diagnosis. 
An enzyme-linked immunosorbent assay (ELISA) introduced by Sada et al 
was standardized to detects the presence of mycobacterial antigens in 
the CSF from patients with meningitis. Pleural and ascitic fluid 
samples from patients with pulmonary and abdominal TB were also tested 
for the presence of soluble mycobacterial antigens. 
Antibody directed against M.bovis BCG and coupled to alkaline 
phosphatase was used in the assay. The test sample was pre-incubated 
with an optimal dilution of unconjugated antibody. If antigens were 
present in the CSF, pleural or ascitic fluid, these would combine with 
the antibody to form an immune-complex. When the solid-phase antigen 
(BCG) was reacted with this pre-incubated mixture, no antibody would 
be available to complex with the solid-phase BCG antigen. Hence, the 
antibody-enzyme complex would have no binding site and no colour 
production would result. 
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If, on the other hand, no antigen were present in the test specimen, 
antibody from the pre-incubated sample would attach to the solid-
phase antigen (BCG)• The antibody-enzyme complex, when added, would 
link onto the antibody-solid phase antigen complex. When the enzyme 
substrate is introduced, this would be acted upon by the enzyme to 
produce a colour reaction product (PLATE 2). The intensity of the 
colour produced is proportional to the amount of hydrolysis under-
taken by the enzyme and also to the amount of soluble antigen in the 
test sample. Fig. 5 illustrates the above. 
Before the ELISA could be employed in the diagnosis of TBM, the 
technique had to be standardized. The variables that existed are 
listed below: 
(i) Types of microtitre plate 
<conjugate antibody solid-phase antigen 
(iii) Time (length of incubation) 
(iv) Temperature (of incubation) 
Each of the above-listed criteria was investigated in detail before 
the ELISA was utilized to detect mycobacterial antigens in CSF. 
(i) Testing of Microtitre plates for acceptability 
(Voller, A., Bidwell, D.E. and Bartlett, A.) 
Reagents: All reagents prepared under sterile conditions. 
(1) Coating buffer 




100 ng/ml solution made up in coating buffer 
(3) Washing buffer 
0,01M phosphate-buffer saline (PBS) pH 7,4 and 0,05% 
Tween 20 (polyoxyethylene sorbitan monolaurate) 
(4) Conjugate 
Alkaline-phosphatase conjugated (Rabbit) Anti-Human IgG 
M.A. Bioproducts B30-315. 
(5) Substrate 
p-nitrophenylphosphate disodium salt (Merck Cat. No. 6850) 
(6) Substrate Buffer 
10% Diethanolamine buffer pH 9,8 containing 0,2% NaN 
(7) Plastic Microtitre plates 
(a) Titertek polyvinylchloride immunoassay plate 
• ^ 77-773-05. Activated. 
(b) Dynatech. Removastrip Systems of Immulon 
polyvinylchloride immunoassay wells 
(c) Nunc flat-bottomed polystyrene immunoassay plate -^pf-442404. 
(d) Nunc flat-bottomed polystyrene immunoassay strips 
^ 4 6 9 9 1 4 . Modules F-16. 
(8) IN NaOH 
Procedure: (under sterile conditions) 
Microtitre plates were checked by adding 200 \i£ of human IgG solution 
(100 ng/ml) made up in coating buffer to each well and incubating 
overnight at 4°C. 
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The coating solution was aspirated and each well was washed three 
times with PBS-Tween. 200 \xl of conjugate (diluted /1000 in PBS-
Tween) was then added to each well and incubated for 18 hours at 4 C. 
The conjugate was removed by aspiration and the wells were again 
washed three times with PBS-Tween. 
A fresh solution (1 mg/ml) of the substrate was made up in diethanol-
amine buffer and 200 u& was added to each well and incubated for 30 
minutes at room temperature. 
The reaction was stopped by adding 50 \xl of IN NaOH to each well. 
Absorbance of contents of each well was read at 405 nm. The plate 
giving the least total variation of values was chosen for use in 
the test. NUNC flat-bottomed plates ̂ 442404 were found to be most 
acceptable. (Table VI). 
• 
(ii) Determination of optimal test conditions 
(a) Enzyme Immunoassay (EIA) for Alkaline Phosphatase conjugates 
The method used to determine the working dilution of the alkaline 
phosphatase conjugates was supplied by Bio-Yeda Ltd. of Kiryat 
Weizmann/Rehovot/Israel. 
Reagents: All reagents prepared under sterile conditions. 
(1) Coating buffer 
Bicarbonate buffer - 0,05M pH 9,5 
(2) Antigen 
Behring Human IgG (y-chain). 
Concentration of antigen was 2,9 g/£. Diluted 966 u£ antigen in 
13034 u£ coatine buffer to make a 200 u£/ml solution. 
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(3) Conjugate 
Alkaline-phosphatase conjugated goat anti-rabbit IgG(H+L). 
Bio Yeda Code No 4471. 
Dilutions of 1:100; 1:150; 1:200; 1:300; 1:800; 1:1200; 1:1600; 
1:2400 and 1:3200 were made up in washing buffer under sterile 
conditions. 
(4) Negative Control or Blank 
Bovine serum albumin (BSA) from Sigma Chemical Co 
No A-403. Fraction V powder 96-99% albumin. 
Diluted 0,002g BSA in 5 ml PBS pH 7,4 to make a 200 ug/ml solution. 
(5) Phosphate-Buffer Saline (PBS) 
0,01M phosphate buffer pH 7,4 containing 0,15 M NaCl and 0,1% NaN„. 
(6) Washing Buffer 
PBS and 0,05% Tween 20 (polyoxyethylene sorbitan monolaurate). 
(7) Substrate buffer 
10% Diethanolamine buffer pH 9,8 containing 0,2% NaN3< 
(8) Substrate 
p-nitrophenyl phosphate disodium salt (MERCK Cat. No 6850) 
Dissolved immediately prior to use in substrate buffer. 
This was done by pre-warming 12 ml of substrate buffer to 
room temperature and then adding 12 mg of substrate to give 
a final concentration of 1 mg/ml. 
(9) Polystyrene tubes 12 x 75 mm 
(10) NaOH - IN 
(11) H O - distilled water 
Procedure (under Sterile Conditions) 
(1) The polystyrene tubes were coated by pipetting 1 ml of antigen 
solution (200 ug/ml) into each tube. The tubes were covered 
with parafilm and incubated overnight at room temperature. 
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(2) The coating solution was aspirated and the tubes were washed 
three times with PBS + Tween 20 and then three times with 
water, aspirating each time. 
(3) Various dilutions of the conjugate, ranging from /100 to /3200 
were made up in washing buffer. One ml of each dilution was 
added to each of the polystyrene tubes. The tubes were then 
covered with parafilm and incubated at room temperature for two 
hours. 
(4) The conjugate solution was removed by aspiration and the tubes 
were washed as in step (2). 
(5) 1 ml of freshly prepared 1 mg/ml substrate solution was then 
added to all 12 tubes. These were incubated at room temperature 
for 30 minutes. 
(6) At the end of the incubation period 0,4 ml NaOH was added to 
terminate the reaction. 
(7) The absorbance of each tube was read at 405 nm using a Beckman 
spectrophotometer. 
A 200 yg/ml solution of BSA was used as a blank. 
(8) The dilution of conjugate which gave an absorbance reading of 
approximately 1,0 was chosen as the working dilution for enzyme 
immunoassays. (This was found to be a 1:2000 dilution). 
Fig 12, Table V. 
(b) Selection of optimum amount of the solid-phase antigen (chequer-
board titration using l-'.ycc'caeteviur. bcvis BCG antigen and reference 
sera) 
The methods used to determine the optimal concentrations of M.bovis 
BCG antigen for coating the microtitre plates was adapted from a 
(52) 
method used by Voller et al, for measles antigen. 
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Reagents: All reagents prepared under sterile conditions. 
(1) Antigen 
BCG VACCINE (DRIED). Japanese strain 172. Total mass 24 mg. 
Manufactured by Dept. of Health and Welfare, State Vaccine 
Institute, Cape Town. 
Reconstitution of one vial with 0,3 ml sterile distilled water. 
Resulting BCG solution 80 000 yg/ml. 10 u£ of this solution 
mixed with 4990 \i2 coating buffer resulted in STOCK ANTIGEN 
solution (160 yg/ml BCG). Required BCG antigen solutions in 
the following concentrations (yg/ml): 20; 10; 5; 2; 0,5; 0,2. 






























Carbonate-bicarbonate buffer 0,05 M pH 9,5 
Washing buffer 
0,1 M phosphate-buffered saline (PBS) pH 7,4 and 0,05% Tween 20. 
Reference sera 
POSITIVE SERUM - Rabbit IgG anti-BCG. Dakopatts Code No B124. 
NEGATIVE SERUM - Normal rabbit serum. Dakopatts Code No X903 
1 1 





sera made up in washing buffer in polystyrene tubes. 
(5) Conjugate 
Alkaline-phosphatase conjugated goat anti-rabbit IgG (H + L). 
Bio Yeda Code No 4471. 
A /2000 dilution was made up by mixing 5 u£ conjugate with 
9995 \il washing buffer under sterile conditions. 
(6) Substrate 
p-Nitrophenylphosphate disodium salt (Merck Cat No 6850). 
Dissolved < 30 minutes prior to use in diethanolamine buffer 
to form a 1 mg/ml solution. 
(7) Substrate buffer 
10% Diethanolamine buffer pH 9,8 containing 0,2% NaN 
(8) IN NaOH 
(9) Nunc microtitre plate >^ 442404 
(10) Humidity chamber 
Airtight plastic container lined with damp 'Spontex' sponges. 
Procedure : Under Sterile Conditions 
(1) Various dilutions of the BCG antigen (20 ug/m£; 10 \ig/ml; 5 \ig/ml; 
2 yg/m£; 0,5 yg/mJi and 0,2 yg/m£) were made up in coating buffer. 
A microtitre plate was divided into halves by a vertical line 
through the centre. 100 u£ of each dilution was added to a 
vertical row of wells in each half of the microplate. The plate 
was incubated with a lid, overnight in a humid box at +4 C. This 
allowed the antigen to absorb to the plastic surface. 
(2) The wells were emptied by aspiration, then washed by the addition 
of 250 y£/well of PBS-Tween, leaving for a few minutes and emptying 
This process was repeated 3 times and plates were then shaken dry 
and allowed to drain on 'Spontex' sponges. 
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(3) 50 \il of two reference sera (positive and negative for anti-
bodies to BCG antigen) serially diluted in PBS Tween were added 
to vertical rows of wells so that each serum dilution was 
reacted with each antigen dilution. A row containing only 
PBS Tween was included. Plate was then incubated 2 hours at 
room temperature in a humid box. 
(4) Plates were emptied by aspiration then washed as before. 
(5) The stock conjugate was diluted in PBS-Tween and 50 \xi amounts 
were added to each well. The plate was then incubated for 3 hours 
at room temperature. Plates were emptied and washed as before., 
(6) 50 (ii of substrate solution were added to each well and 
incubation was allowed to proceed at room temperature for 30 
minutes. The reaction was stopped by the addition of 25 \xi 
IN NaOH to each well. 
(7) Absorbance of contents of each well was read at 405 nm with an 
EIA Reader Model EL-307, BI0-TEK INSTRUMENTS, INC. 
(8) The combination of the antigen/serum dilutions which gave 
maximal separation between positive and negative test samples 
but still gave low negative values (under 0,2) was chosen for 
the subsequent tests. (Table VII, Fig 13.) Results on page 76. 
(c) Optimal Antibody dilution required for inhibition assay 
In order to attain maximal inhibition of interaction between the 
solid-phase antigen (M.bovis 3CG) and the antibody - enzyme conjugate, 
the inhibition assay had to be standardized. 
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Various dilutions of antibodies raised against BCG (rabbit IgG anti-
BCG, DAKOPATTS), ranging from /800 to V3200 were made up in PBS 
containing 0,05% Tween 20 and 1% BSA. These various dilutions were 
mixed, in 100 \ii amounts, with 100 \il of BCG standard solutions 
(0; 0,002; 0,02; 0,2 and 20 pg/mJi) so that each antibody dilution 
was reacted with each BCG dilution. This was incubated overnight 
at 4 C. The inhibition assay was then carried out as described in 
the foregoing; and the absorbance was recorded. 
A 1:1200 anti-BCG dilution was chosen to interact with 0,1 ml CSF 
in the inhibition assay (Fig 14). 
(d) Sample and Conjugate Incubation 
The ELISA technique described on Page 43 was carried out using sample 
and conjugate incubation periods ranging from 1 hour at 45 C and 2-3 
hours at 37 C to overnight at 4 C in order to determine optimal 
incubation periods. No significant differences were obtained after 
incubation for 1 hour at 45 C, 2-3 hours at 37 C, or overnight at 4 C 
(iii) Patients 
A total of 84 samples were studied. Of these, 59 were CSF samples 
and 25 were pleural and ascitic fluid samples. All samples were 
collected from King Edward VIII Hospital, Durban together with a 
case-history and details of clinical examination. 
The samples were subject to the following investigations: 
(1) Routine cytological and biochemical tests were done, 
using standard techniques. 
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(2) Culture for M. tuberculosis - a loopful of sample was streaked 
on LJ medium and incubated at 37 C for 8 weeks. Smears were 
prepared from growth, if any, and stained with Ziehl-Neelsen's 
technique. 
(3) ELISA was done on each sample as described in the foregoing. 
(4) All patients were followed up as far as possible to confirm 
or reject the initial diagnosis. 
Of the 59 CSF samples; 3 were culture-positive M. tuberculosis 
specimens; 7 were diagnosed as being TBM on the basis of autopsy 
findings, or recovery on anti-tuberculous treatment. Ten CSF samples 
were from culture-positive bacterial meningitis patients. Twenty-
five control samples were from patients who were admitted with signs 
of meningeal irritation but had normal CSF profiles. Fourteen 
samples were from patients with aseptic (viral) meningitis. 
Of the 25 pleural and ascitic fluid samples; 15 were diagnosed as 
being from patients with pleural and abdominal tuberculosis on the 
basis of culturing, acid-fast staining, or recovery with anti-
tuberculous treatment. Ten control samples were collected from 
patients with ascites caused by malignancies, bilharzia, trauma or 
amoebiasis. 
The criteria used to diagnose TBM, viral (aseptic) and bacterial 
meningitis are listed on Pages 6 and 7. 
(iv) Antigen Coating of Microtitre Plates 
Reagents: Prepared under sterile conditions. 
(1) Coating buffer 
Carbonate-bicarbonate buffer 0,05 M pH 9,5 
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(2) Microtitre plates 
NUNC flat-bottomed polystyrene immunoassay plate. ̂ ^442404 
(3) Antigen 
BCG Vaccine (DRIED). Japanese strain 172. Total mass 24 mg. 
Manufactured by Dept of Health and Walfare, State Vaccine 
Institute, Cape Town. 
Reconstitution of one vial by addition of 0,3 ml sterile 
distilled water. Diluted this reconstituted vaccine in 
coating buffer to produce a 10 yg/m£ solution of BCG. 
This was done by adding 5 y£ of reconstituted vaccine 
(80 000 ug/mC concentration) to 995 y£ coating buffer, 
hence a 400 yg/ml solution resulted. Diluted this further 
in 39 m£ coating buffer and stored in aliquots at -70°C. 
(4) Blocking buffer 
0,5% Bovine Serum Albumin (BSA). Sigma No A-403. 
Dissolved in phosphate-buffer saline (PBS) 0,01 M pH 7,4 
(5) Washing buffer 
0,01 M PBS pH 7,4 and 0,05% TWEEN 20 and 1% BSA 
(6) Humid box 
Procedure: Under Sterile Conditions 
(1) Wells in a microtitre plate are sensitized by addition of 100 \iZ 
amounts of a 10 yg/ml BCG antigen solution to each well, followed 
by overnight incubation at 4CC in a humid box. 
(2) The wells are emptied by aspiration of coating solution. 
(3) The remaining binding sites on the surface of each well 
are blocked by the addition of 250 y£/well of PBS-BSA, then 
incubating for 1 hour at room temperature. 
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(4) The wells are emptied by aspiration. 
Each well is washed by the addition of 250 \i& washing buffer, 
waiting for 5 minutes, then emptying by aspiration. This 
washing procedure is repeated three times. 
The sensitized plate is then shaken dry and allowed to drain 
on 'Spontex' sponges. 
(5) Sensitized plates are sealed individually in aluminium foil 
and stored at -70°C for up to 6 months. 
(v) Elisa Technique 
(Fig. 5) 
(52) 
The method used was described by Voller et al, (1976) ' . The 
method was modified and standardized before it could be applied in 
the detection of mycobacterial antigens. 
Reagents: Prepared under sterile conditions. 
(1) Antibody 
Rabbit IgG anti-Bacillus Calmette-Guerin (BCG) 
DAKOPATTS Code B124 
\ 
Diluted /1200 in washing buffer 
(2) Antibody-Enzyme Conjugate 
Alkaline-phosphatase Conjugated anti-rabbit IgG (H+L) 
Raised in goat. BIO YEDA code no 4471 
(3) Substrate 
p-Nitrophenyl phosphate disodium salt (MERCK CAT. NO 6850) 
Dissolved < 30 minutes prior to use in diethanolamine buffer 
to form a 1 mg/mC solution. 
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Substrate buffer 





0,01 M PBS pH 7,4 and 0,05% TWEEN 20 and 1% BSA 
NUNC flat-bottomed microtitre plate ̂ T442404 coated with 
BCG solution (10 yg/ml). 
Procedure: Under Sterile Conditions 
(1) 100 y£ amounts of both the first antibody and the sample to 
be tested are mixed together in an unsensitized well and 
incubated overnight at 4°C in a humid box. 
(2) 100 y£ amounts of the contents from each unsensitized well 
is then transferred carefully by pipetting (without disturbing 
any sediments) into a corresponding well in an antigen-
sensitized microtitre plate. 
The sensitized plate is then covered and incubated overnight 
at 37°C in a humid box. 
(3) The wells are emptied by aspiration then washed by adding 250 \i£ 
amounts of washing buffer, leaving for a few minutes, then 
emptying. This washing procedure is repeated three times. 
(4) 100 y£ amounts of conjugate (diluted /2000 in washing buffer) 
are added to each well. The plate is then covered and incubated 








(5) The wells are emptied by aspiration and washed thrice as before. 
(6) 100 ]s2 amounts of freshly prepared 1 mg/m£ p-nitrophenyl 
phosphate solution is added to each well. 
The plate is then incubated for 30 minutes at room temperature. 
(7) The reaction is stopped by the addition of 50 \i2 amounts of 1N NaOH 
to each well. 
(8) Absorbance of contents of each well is read at 405 nm with an 
EIA READER MODEL EL-307; BIOTEK INSTRUMENTS, INC. 
4. Double Antibody Sandwich ELISA 
TBM occurs commonly in developing countries - up to 20 cases per 
100 000 members have been reported in some countries. It is 
virtually impossible for a patient to recover spontaneously without 
treatment. The average duration of the untreated illness is about 
17 days from onset to death. It has been established that a 
correlation exists between the stage of the disease at the commence-
ment of chemotherapy and the prognosis. The earlier the diagnosis 
is made, the better the chances of recovery without major neurological 
sequelae. 
The diagnosis of TBM is made presently on the basis of clinical 
picture, positive Tuberculin skin test, previous exposure to TB, and 
on the CSF profile (both cytological and biochemical). In addition, 
other methods such as the radioactive bromide partition ratio and the 
CSF adenosine deaminase activity are used in the diagnosis of TBM. 
These methods prove helpful but are certainly not confirmatory in the 
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diagnosis of TBM. Sophisticated and expensive equipment that is 
required is usually not available in the rural areas where the 
incidence of TBM is high. 
Various factors had to be investigated and standardized before the 
double antibody sandwich ELISA could be utilized to detect mycobacterial 
antigens in CSF. These preliminary studies are listed below: 
(i) Conjugation of the enzyme to anti-BCG. 
(ii) Testing the acceptability of various microtitre plates. 
(iii) Optimal dilutions of: 
(a) conjugate 
(b) solid-phase antibody 
(iv) Optimal incubation conditions of: 
(a) time 
(b) temperature. 
The methods used to investigate the above-mentioned criteria are 
discussed below. 
(i) Conjugation of Alkaline-phosphatase to antibodies raised against BCG 
Conjugation of the enzyme to rabbit immunoglobulin G (igG) raised . 
against BCG antigens was done by the 'Two-step glutaraldehyde method' 
of Avrameas (1969). 
Reagents: prepared under sterile conditions 
(1) Antibody 
Rabbit IgG Anti-Bacillus Calmette-Guerin (BCG) 
Dakopatts )$<• B124. 
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(2) Enzyme 
Phosphatase, alkaline from calf intestine. Cat. No. 108 138. 
Boehringer Mannheim. Ammonium sulphate suspension. 
(3) Phosphate-buffer saline (PBS) 
pH 6,8 
(4) TRIS buffer 
0,05 M, pH 8,0 
(5) TRIS buffer 
0,05 M, pH 8,0 containing 1% albumin, bovine serum (BSA) and 
0,02% sodium azide (NaN ) 
(6) Glutaraldehyde - 25% aqueous solution 
(7) Dialysis tubing 
Procedure: 
(1) The protein content of the antibody and the enzyme were 
determined by the standard 'Lowry method1 (Appendix A ) . 
(2) 40 \i£ of the IgG (protein content 10 mg/m£) is added, 
together with 160 u£ alkaline-phosphatase (protein content 
0,8 mg/161 u£), and 200 \i£ PBS pH 6,8, into a dialysis sac 
and mixed at room temperature. The mixture is then dialysed 
for 18 hours at 4°C against PBS (with changes of buffer) to 
remove ammonium sulphate. 
(3) While the solution is gently stirred, 27 \i£ of a 25% aqueous 
solution of glutaraldehyde is added to yield a final 
concentration of 0,2%. The mixture is allowed to react at 
room temperature for 2 hours; then is dialysed overnight at 
4°C against PBS with several changes of buffer. 
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(4) The dialysis sac containing the conjugate is transferred to 
0,05 M TRIS buffer pH 8,0 and dialysed overnight at 4°C with 
changes of buffer. 
(5) The dialysis sac contents (conjugate) is diluted to 2,0 ml 
with 0,05 M TRIS buffer containing 1% BSA and 0,02% sodium 
azide, then is stored in the dark at 4°C. 
(ii) Testing of Plates for acceptability in Double Antibody 
Sandwich ELISA 
This was done by the same method as that used to test the acceptability 
of plates for the Inhibition ELISA. The method is detailed on Page 32. 
(iii) Determination of Optimal test conditions 
(a) Working dilution of the Enzyme-Antibody conjugate 
The method used to determine the optimal dilution for the alkaline-
phosphatase labelled rabbit IgG anti-BCG conjugate used in the DOUBLE 
ANTIBODY SANDWICH ELISA was similar to that for the conjugate used in 
the INHIBITION ELISA. This method is detailed on Page 34. Dilutions 
of the conjugate ranging from 1:50 to 1:3200 were assayed to select a 
dilution which gave an absorbance of approximately 1,0 which was 
considered optimum. 
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(b) Selection of optimum amount of solid-phase antibody -
(chequerboard titration using antibodies raised against 
Mycobacterium bovis BCG and reference antigens) 
The method used to determine the optimal concentrations of rabbit 
immunoglobulin G (IgG) raised against BCG required for coating the 
(52) 
microtitre plates was adapted from that of Voller et al, for 
measles antigen. 
Reagents: Prepared under Sterile Conditions 
(1) Antibody 
Rabbit IgG anti-Bacillus Calmette-Guerin (BCG) 
DAKOPATTS Code No. B124 
1 1 
Serial dilutions ranging from /100 to /3200 made up in 
coating buffer (in sterile polystyrene tubes). 
(2) Coating buffer 
Carbonate-bicarbonate buffer 0,05 M pH 9,5 
(3) Washing buffer 
0,01 M phosphate-buffer saline (PBS) pH 7,4 and 0,05% TWEEN 20 
(4) Reference antigens 
Negative antigen - Albumin, Bovine (BSA). Fraction V powder, 
96-99% albumin. SIGMA A-4503. 
Positive antigen - BCG VACCINE (Dried). Japanese strain 172. 
Total mass 24 mg. Reconstituted with 0,3 ml. sterile distilled 
water. 5 y£ of reconstituted solution mixed with 9995 y£ washing 
buffer to produce 40 pg/m£ stock BCG solution. 
Both negative and positive antigens are diluted with washing 
buffer to produce solutions with the following concentrations: 




Rabbit IgG anti-BCG conjugated to alkaline phosphatase. 
A /100 dilution of the conjugate is made up in washing 
buffer by mixing 0,1 ml conjugate and 9,9 ml buffer. 
(6) Substrate 
p-Nitrophenyl phosphate disodium salt. (Merck -̂fc 6850). 
Dissolved < 30 minutes prior to use in substrate buffer 
to produce 1 mg/ml solution. 
(7) Substrate buffer 
10% Diethanolamine buffer pH 9,8 containing 0,2% sodium azide, 
(8) 1N NaOH 
(9) Micro-ELISA reader 
EIA READER MODEL EL-307, BIO-TEK INSTRUMENTS, INC. 
(10) NUNC flat-bottomed microtitre plate >&442404. 
Procedure: Under Sterile Conditions 
(1) Serial dilutions of the antibody (Rabbit IgG anti-BCG) ranging 
from /100 to /3200 are made up in coating buffer. 50 \i2 of 
each dilution are added to a vertical row of wells in each half 
of the microplate. The plate is divided by a vertical line 
running down the centre. 
The plate is covered and incubated overnight at 4°C in a humid 
box. This allows the antibody to absorb to the plastic surface. 
(2) The plate is emptied by aspiration, then washed by adding 250 pi/we11 
of washing buffer, leaving a few minutes, then emptying. This 
process is repeated three times and plate is then shaken dry. 
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(3) 50 \i£ of two reference antigens (positive and negative for 
antibodies to BCG antigen), in solutions of various concentrations 
(refer to 'Reagents') are added to horizontal rows of wells so 
that each antibody dilution is reacted with each antigen dilution. 
A row containing only washing buffer is included. 
Plate is then incubated 2 hours at room temperature in a humid box. 
(4) Plates are washed as before. 
(5) The stock conjugate (alkaline phosphatase-rabbit IgG anti-BCG) is 
diluted by /100 in washing buffer and 50 y£ amounts are added 
to each well. The plate is then incubated for 3 hours at room 
temperature. 
(6) Plates are washed as before. 
(7) 50 \i£ amounts of substrate solution (1 mg/ml) are added to each 
well and incubation is allowed to proceed for 30 minutes at room 
temperature. The reaction is stopped by the addition of 25 u£/well 
of 1N NaOH. 
(8) Absorbance at 405 nm is read in a micro-ELISA reader. 
The combination of the serum/antigen dilution which gives 
maximal separation between positive and negative test samples 
but still gives low negative values (under 0,2) is chosen for 
subsequent tests. 
Fig 18, Table XI. 
(c) Sample and Conjugate Incubation 
The DOUBLE ANTIBODY SANDWICH ELISA technique was carried out using 
commercial BCG protein solutions for the test samples. Sample and 
conjugate incubation times of 1 hour at 45°C; 2-3 hours at 37°C and 
overnight at 45°C were experimented with. 
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(d) Colour development 
The intensity of colour developed is controlled by the conjugate 
concentration and time allowed for development. Using a 30 minute 
incubation period at room temperature, the working dilution of the 
conjugate was found to be uneconomical, therefore, the following 

















A total of 20 CSF samples were collected from patients with various 
clinical signs of meningeal irritation. A detailed case-history and 
a record of the clinical examination was also collected. The CSF 
samples underwent the following investigations: 
(1) Routine cytological and biochemical tests were performed 
by using standard techniques. 
(2) ELISA was performed on all samples by the method described 
in the foregoing. 
(3) A follow-up of the patient was made to determine whether the 
initial diagnosis was accurate. 
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The CSF profile of all 20 patients proved to be normal in the final 
analysis and the majority had completely recovered within 5-7 days. 
The double antibody sandwich ELISA was carried out initially on the 
above-mentioned normal CSF samples. In addition, a row of wells 
containing positive commercial BCG standards was included. When it 
was found that no distinction could be made between the absorbance 
values obtained with the normal CSF's and those of the positive 
standards, no further testing was done on CSF samples from patients 
with TBM or bacterial meningitis. 
(v) Antibody Coating of Plates 
Reagents: Prepared under Sterile Conditions. 
(1) Solid-phase Antibody 
Rabbit IgG-anti-Bacillus Calmette-Guerin (BCG) 
DAKOPATTS CAT. No. B124. 
1 . . 
A /800 dilution (as determined by chequerboard titration) 
of the antibody is made up in coating buffer by mixing 10 y£ 
with 7990 \it> coating buffer. 
(2) Coating buffer 
Carbonate-bicarbonate buffer 0,05 M pH 9,5 
(3) Blocking buffer 
0,01 M PBS pH 7,4 and 0,5% BSA 
(4) Washing buffer 
' 
0,01 M PBS pH 7,4 and 0,05%. Tween 20 and 1% BSA 
(5) Microtitre plates 
NUNC flat-bottomed polystyrene immunoassay plate $'442404 
(6) Humid box 
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Procedure: Under Sterile Conditions 
(1) 100 u£ amounts of optimally diluted anti-BCG antibodies (diluted 
in coating buffer) is added into the wells of a microplate. 
The plate is covered and incubated overnight in a humid box 
at 4°C. This allows the antibodies to be adsorbed onto the 
plastic surface. 
(2) The wells are emptied by aspirating the coating solution. 
(3) 250 \i2 amounts of blocking buffer are added to each well. 
The plate is then covered and incubated at room temperature 
for 1 hour. This permits the remaining unblocked binding 
sites on the plastic surface to be filled by BSA, hence non-
specific binding is reduced. 
(4) The wells are emptied by aspiration and washed by adding 250 y£ 
amounts of washing buffer, leaving for a few minutes, then 
emptying. 
This washing procedure is repeated three times, then the plate 
is shaken dry and allowed to drain on 'Spontex' sponges. 
(5) Sensitized plates may be sealed individually in aluminium foil 
and stored at -70°C. 
(iv) ELISA Technique 
This method to detect soluble M.tubevouZosis antigens in the various 
body fluids of tuberculous and other groups of patients was essentially 
(22) . . 
that of Engvall and Perlmann. The method was further modified by 
(47) 
Sada et al, and this latter version was used in our study (Fig. 6). 
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Reagents: Prepared under sterile conditions 
(1) Antibody-Enzyme Conjugate 
Alkaline-phosphatase labelled rabbit IgG anti-BCG. 
1 
A /150 dilution (as determined by titration) of the conjugate 
is made up in washing buffer by the addition of 25 \iZ conjugate 
to 3725 y£ buffer. 
(2) Washing buffer 
0,01 M PBS pH 7,4 and 0,05% TWEEN 20 and 1% BSA 
(3) Positive Control Antigen 
Commercial BCG protein standards containing 0, 2, 3, 7 and 14 ng 
BCG are made up in washing buffer. 
(4) Substrate 
p-nitrophenyl phosphate disodium salt (MERCK CAT. No. 6850). 
Dissolved < 30 minutes prior to use in diethanolamine buffer 
to form a 1 mg/m£ solution. 
(5) Substrate buffer 
10% Diethanolamine buffer pH 9,8 containing 0,2% sodium azide. 
(6) 1 N NaOH 
(7) Humid box 
(8) Micro-ELISA reader 
Procedure: Under sterile conditions 
(1) 100 \i2 amounts of each sample to be tested is added to a well 
in a sensitized microtitre plate, (in duplicate, quantity 
permitting). 
A row of wells containing commercial BCG standard solutions are 
included to serve as a positive control. 
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(2) The plate is covered and incubated for 2 hours at 37°C in a 
humid box. 
(3) The wells are emptied and washed by the addition of 250 \i£ 
amounts of washing buffer to each well, leaving for a few 
minutes, then emptying. This washing procedure is repeated 
three times. 
(4) 100 ]i£ amounts of optimally diluted conjugate is added to 
each well and incubated for 3 hours at 37°C in a humid box. 
(5) The wells are emptied and washed as before. 
(6) 100 \i£ amounts of p-nitrophenyl phosphate solution is added 
to each well. Plate is then incubated for 90 minutes at 45°C 
in a humid box. 
(7) The reaction is stopped by the addition of 50 \i£ amounts of 
1N NaOH to each well. 
(8) Absorbance at 405 nm is read with an EIA READER MODEL EL-307, 
BIOTEK INSTRUMENTS, INC. 
5. Statistical Methods 
Statistical analysis of results was carried out by non-parametric 
tests, as no assumptions could be made on the symmetrical distribution 
of sample results about the mean. 
The non-parametric test employed was the 'ONE-WAY ANALYSIS OF VARIANCE' 
Probability values less than 0,01 and 0,05 were taken as significant, 
i.e., 1% and 5% points of variance (F) ratio. Methods used for a 
particular study are given with it. 
Fig. 5 : Inhibition of BCG-anti-BCG Reaction by 
M.tuberculosis antigen using ELISA 
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Fig. 6 : DOUBLE ANTIBODY SANDWICH ELISA for measuring antigen 
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1. CORRELATION BETWEEN CHLORIDE LEVELS IN BLOOD AND CSF OF 
PATIENTS WITH TUBERCULOUS AND OTHER FORMS OF MENINGITIS 
(i) Objectives 
(a) To determine whether any correlation exists between the levels 
of chloride in the blood and CSF of patients with tuberculous 
and other forms of meningitis. 
(b) To determine the BLOOD/CSF chloride ratio in patients with 
bacterial, viral, and tuberculous meningitis. 
(ii) Patients 
Blood and CSF samples were obtained from a total of 149 Black children 
admitted to King Edward VIII Hospital, Durban during the six month 
period, February-August 1985. On the basis of clinical examination, 
routine cytological and biochemical tests on CSF, and culture studies, 
the children were found to have various types of meningitis. The 
children ranged in age from 1 day to 11 years. A detailed analysis of 
the patients studied is recorded in Table II and in Figures 7 and 8. 
(iii) Method 
Chloride levels in both blood and CSF were measured with a fully 
automated instrument, the BECKMAN ASTRA-8 AUTOMATED .STAT/ROUTINE 
ANALYSER. This instrument utilizes the colorimetric titration method 
of measurement. Both the electrode and the cathode consisted of 
silver chloride. Readings were given in mmol/2. 
TABLE II : CHILDREN WITH MENINGITIS AT KING EDWARD VIII HOSPITAL DURING THE 6-MONTH PERIOD 
FEBRUARY-AUGUST 1985 

























































35 + 36,2 
20 + 29,1 
23 + 38,9 
6,8 + 4,4 
29 + 41,6 
1 + 1,5 
2 + 0 
3,5 +_ 2,1 
88,1 + 62,1 
7 2 + 0 
Age Range 
3 mth - 10 yrs 
2d - 9 yrs 
2d - 11 yrs 
5 d - 2 yrs 
2 mth - 7 yrs 
Id - 4 mths 
4 d - 7 mths 




The mean blood chloride (Cl~) level obtained (98,0 mmol/£ _+ 13,2 S.D.) 
fell within the normal range of values (95-105 mmol/£). The mean CSF 
level recorded (107,0 _+ 9,7 (S.D.)) was significantly lower than that 
of the normal CSF Cl~ range (120-130 omol/£). The mean BLOOD/CSF Cl~ 
ratio was found to be 0,943 + 0,032 (S.D.). 
(b) Viral meningitis 
The mean blood Cl level (115,0 _+ 8,7 S.D.) was found to be raised 
substantially in this group of patients. The mean CSF chloride level 
obtained (122,0 _+ 7,4) fell within the lower limit of normal. 
The mean BLOOD/CSF Cl~ ratio was found to be 0,940 +_ 0,003, a value 
very similar to that obtained for patients with TBM. 
(c) Bacterial meningitis 
The mean blood Cl levels for meningitis caused by Streptococcus 
pneumonia, Haemophilus influenzae and Neisseria meningitides were 
all within the normal range. The mean CSF Cl levels, however, fell 
below the lower limit of normal for all three of the above-mentioned 
bacterial meningitis. 
The mean BLOOD/CSF ratio for S.pneumonia was 0,922 ̂ 0,059 (S.D.); 
that for H.influenzae 0,899 +_ 0,217; and that for N.meningitis was 
0,914 + 0,038. 
A detailed analysis of the results obtained is recorded in Table III 
and in Figures 9, 10, and 11. 
Fig. 7 : Incidence of meningitis in males and females (children) at King Edward VIII Hospital 
MALE 
FEMALE 




Fig. 8 : Causative agents of meningitis in children at 
King Edward VIII Hospital during the six-month 
period (February-August 1985) 
S. pneumonia 





Other - Cryptoooaous 
E.Qoli 
Aaxnetobaetev 
TABLE III : BLOOD AND CSF CI LEVELS AND BLOOD/CSF CI RATIO IN BACTERIAL, VIRAL AND TUBERCULOUS GROUPS OF PATIENTS 
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• • ' ' • ' 
Blood/CSF 
Cl" ratio + S.D. 
(0,8)* 
0,943 + 0,032 
0,940 + 0,003 
0,922 + 0,059 
0,899 + 0,217 






0,896 - 0,979 
0,781 - 1,088 
0,818 - 1,034 
0,794 - 1,020 
0,880 - 0,965 
ND 
*normal values 
1. Cl levels in m mol/il 
2. ND = not done. 
4> 
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TBM VIRAL S.pneumonia H.influenzae N.meningitis 
cause of meningitis 
Fig. 9 : Distribution of blood chloride levels in children with meningitis 
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Fig. 10 : Distribution of CSF chloride levels in children with meningitis 
TBM VIRAL S.pneu-
monia 
H.in flu- N.menin- Klebsiella 
enzae gitidis 
-cause of meningitis. 
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Fig. 11 : Distribution of BLOOD/CSF chloride ratio 
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(v) Discussion 
Chloride and bromide are chemically similar. They share physical and 
chemical properties (Table IX) and are hence grouped together as 
'halides'. Studies by Mandal et al (1972), Mann et al (1982)37;38') 
and others have shown that after a loading dose, the relative 
concentrations of bromide in the blood and CSF are normally in a ratio 
of about 3:1. When the blood-brain barrier is damaged, as in the case 
of tuberculous but not in viral meningitis, the bromide ratio in blood 
and CSF tends to equalise. 
It was proposed that a similar situation may exist concerning chloride 
levels in CSF and blood of patients with tuberculous and viral 
meningitis since chloride and bromide were similar chemically. Hence, 
the blood and CSF of 149 patients with various types of meningitis 
were measured for chloride content. A total of 10 patients had TBM; 
34 had viral meningitis; and the rest had bacterial or cryptococcal 
meningitis. The distribution of blood and CSF CI levels that were 
recorded are presented graphically in Figure 9 and 10. Unfortunately 
both the CSF and blood CI levels were not measured in all patients. 
In those where both CSF and blood CI measurements were made, the 
BLOOD/CSF CI ratio was computed. This is recorded graphically in 
Figure 11. 
The value of CSF chloride levels as a diagnostic pointer in cases of 
(43) 
TBM is questionable. Parsons deems the chloride level in the CSF 
(31) as 'no longer thought to be important'. Jaffe, however, states 
that a very low CSF chloride (e.g., under 100 mmol/1) is strongly 
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suggestive of TBM provided that the serum chloride is not also very-
low. Our studies have proven contrary to that of Jaffe. Only two 
patients with TBM had chloride levels less than 100 mmol/1. The 
chloride levels in tuberculous patients was found to range from 
95 mmol/1 to normal values. Those patients with very low chloride 
values (< 100) had serum chloride levels that were equally low. The 
CSF chloride levels in tuberculous meningitis were found to be on the 
low side; no patient had a chloride level greater than that of the 
upper limit of normal (130 mmol/1). All but one patient had CSF 
chloride levels below that of the lower limit of normal (120 mmol/£). 
Depressed CSF chloride levels thus seem indicative of TBM. 
The CSF chloride levels in patients with bacterial and viral meningitis 
is usually normal. Our investigations revealed that in the patients 
with viral meningitis, the majority of CSF fell within or on the 
periphery of the normal range. No patients were found to have greatly 
depressed CSF chloride levels, i.e., < 110 taool/i. In patients with 
bacterial meningitis it was found that the vast majority of CSF 
chloride values fell below the lower limit of normal, i.e., below 
120 mmol/1. A substantial number of these patients had normal CSF 
chloride levels and only one had a chloride level that was raised 
(> 130 mmol/1). Since many patients with bacterial meningitis had 
CSF chloride levels similar or identical to those with TBM, CSF 
chloride levels prove to be unhelpful in the differential diagnosis 
of meningitis. 
Blood chloride levels in patients with bacterial, viral, or 
tuberculous meningitis are stated as remaining normal in the literature. 
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Our studies showed that in patients with TBM, blood chloride levels 
were either depressed, elevated, or normal. In patients with viral 
meningitis no blood chloride levels were depressed; on the contrary, 
the vast majority were elevated. Patients with bacterial meningitis 
had blood chloride levels which largely fell within the normal range 
(95-105 mmol/1), although some were elevated and some were depressed. 
Bacterial, viral, or tuberculous meningitis could not be distinguished 
on the basis of blood chloride levels. 
The BLOOD/CSF chloride ratio is normally in the range 0,75-0,85. In 
all patients with TBM this ratio was found to be elevated (all ratios 
calculated were > 0,89). Patients with bacterial and viral meningitis 
had ratios which were largely raised. A few had normal ratios. 
Patients could not be distinguished as having bacterial, viral, or TBM 
on the basis of the BLOOD/CSF chloride ratio. 
(vi) Conclusion 
On the basis of our investigations of 149 children with tuberculous, 
viral, and bacterial meningitis, the following conclusions have been 
reached: 
(a) CSF chloride values are of little value in discriminating 
between bacterial, viral and tuberculous meningitis. However, 
once the diagnosis of bacterial meningitis has been eliminated, 
uncommonly low CSF chloride values may be associated with TBM 
but not with viral meningitis. 
(b) Blood chloride values of patients with bacterial, viral or 
tuberculous meningitis do not provide a marker by which the 
patients may be separated into their respective aetiological 
groups. 
(c) The BLOOD/CSF chloride ratio in patients with bacterial, 
viral, and TBM is elevated as compared to that of normal 
individuals. The normal BLOOD/CSF chloride ratio is generally 
accepted as falling in the range 0,75-0,85, hence a control 
group of patients with normal CSF was not included in the 
study. 
(d) The BLOOD/CSF chloride ratio does not provide a basis for 
distinguishing bacterial, viral or tuberculous meningitis 
patients as such. 
TABLE IV : PHYSICAL PROPERTIES OF THE HALIDES 
(after Sissler, et al) (48) 
PROPERTY F CI Br At 
1,36 
0 . 7 2 









3 . 5 4 
2 . 1 6 
1.35 
10 .4 
3 . 2 4 
X ion radius (£) 
Atomic radius 
1st ionization energy (ev) 1 4 0  4 9.5 
Electron affinity (ev) 
Electronegatvity 
(Pauling scale) 4.0 3.0 2.8 2.5 2.2 
Heat of hydration of 
X (kcal/mole) -122 -89 -81 -72 
E ,X + 2e~ = 2X~ 
(volts) +2.87 +1.36 +1.07 +0.54 +0.3 
Bond energy (kcal/mole) 37.8 58.0 46.1 36.1 27.7 
Melting point (°C) -223 -102.4 -7.3 113.7 
Boiling point (°C) -188 -34.0 57.8 184.5 
Density (g/cc) 1.1 1.57 3.14 4.94 
(-188°) (-34°) (25°) (25°) 
Color pale yellow- red- violet- black 
yellow green brown black 
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2. INHIBITION OF BCG-ANTI-BCG REACTION BY M.tuberculosis 
ANTIGEN USING ELISA 
(i) Objective 
To ascertain whether the rapid and accurate diagnosis of TBM may be 
made by using an inhibition ELISA to detect soluble M. tuberculosis 
antigens in CSF. 
(ii) Patients 
A total of 84 samples of CSF, pleural and ascitic fluid were collected 
from Black patients treated at King Edward VIII Hospital, Durban. The 
samples consisted of 59 CSF's and 25 pleural and ascitic fluid 
specimens. 
Of the 59 CSF specimens, 10 were from culture-positive bacterial 
meningitis patients, 10 were from patients with a definite or highly 
probable diagnosis of TBM; 14 were from patients with viral (aseptic) 
meningitis; and 25 were from patients who had complaints other than 
meningitis but who nevertheless required lumbar punctures. The 
diagnosis of TBM, viral and bacterial meningitis were made on the 
criteria listed previously in the 'Introduction' and under 'Methods'. 
Of the 25 pleural and ascitic fluid samples, 15 were diagnosed as 
being from patients with pleural and abdominal tuberculosis on the 
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basis of acid-fast staining, culturing, or recovery with anti-
tuberculous treatment. Ten control samples were collected from 
patients with ascites caused by malignancies (2 samples - exudates); 
bilharzia (3 samples - transudates); trauma (3 samples - transudates), 
and amoebiasis (2 samples - exudates). 
(1) Definite or Highly probable diagnosis of TBM - CSF samples of 
10 cases showing clinical features and CSF profiles of TBM were 
investigated for the presence of mycobacterial antigens and cultured 
on Lowenstein-Jensen (LJ) medium. Of these, the diagnosis of TBM 
could be made in all cases by various methods. In three, pathogenic, 
slow-growing, acid fast bacilli could be isolated on LJ medium. Two 
others showed evidence of TBM at autopsy. Five patients showed 
distinct clinical improvement with anti-tuberculous treatment and the 
CSF pictures showed a trend to normal after 4-6 weeks. 
(2) Normal CSF samples - There were 25 patients in this group. 
These were admitted for a variety of complaints ranging from fever, 
convulsions, signs of meningeal irritation, coma, and pseudobulbar 
palsy, all of which necessitate lumbar puncture. The CSF picture 
was normal. All the patients recovered completely within 7—10 days. 
(3) Definite or highly probable diagnosis of bacterial meningitis -
CSF samples of ten acutely ill patients with clinical signs of 
bacterial meningitis were included in the study. These samples were 
confirmed to be from patients with bacterial meningitis when cultures 
of S.pneumonia, E.aoli, N.mengitidis, E. influenzae &. Klebsiella sp. 
were identified. Of the ten patients under study, two died whilst 
the other eight recovered with routine antibiotic treatment in about 
2-4 weeks (Table VIII(a)). 
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(4) Highly probable diagnosis of viral (aseptic) meningitis -
CSF samples from 14 patients with a clinical picture of viral meningitis 
were included in the study. Diagnosis in all cases was based on the CSF 
characteristics, including normal glucose and failure to grow bacteria 
on culture. In all cases recovery was rapid and complete with no 
sequelae. 
(5) Definite or highly probable diagnosis of abdominal tuberculosis -
Ascitic fluid samples of 10 cases showing clinical features of 
abdominal tuberculosis were included in the study. Diagnosis in all 
10 cases was confirmed by either isolation and culture of the tubercle 
bacillus, histology of a biopsy specimen, or prompt response to anti-
tuberculosis chemotherapy (Table VIII(b)). 
(6) Definite or highly probable diagnosis of pleural tuberculosis -
Five pleural fluid samples from patients with a clinical picture of 
pleural TB and mononuclear pleocytosis were included in the study. 
Diagnosis was later confirmed in all 5 cases by either culture or 
direct smear of pleural fluid, histologic examination of pleural 
biopsy specimen, or prompt response to anti-tuberculous therapy. 
(7) Non-tuberculous Ascitic fluid samples - There were 10 patients 
in this group. These were admitted with a variety of complaints 
ranging from amoebiasis, bilharzia, malignancy and trauma. 
(iii) Method 
The ELISA had to be standardized before mycobacterial antigens could 
be detected in pleural, ascitic, or cerebrospinal fluid. Optimal 
conditions of temperature, incubation time, conjugate, coating antigen 
and antibody concentrations were determined for each step of the assay. 
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(iv) Results 
(a) Standardization of ELISA 
Selection of optimum dilution of the antibody-enzyme conjugate -
Absorbance of approximately 1,0 given by 1:2000 dilution of the 
conjugate was considered optimum and was selected for the next 
step. (Fig. 12 and Table V). 
Selection of the Solid-Phase - NUNC flat-bottomed polystyrene 
immunoassay plates £?r 44 2404 were found to be most acceptable for 
use in the ELISA (Standard deviation from the mean was + 0,047 as 
compared to 0,056; 0,049; and 0,072 for the other plates. (Table VI). 
Selection of optimum amount of the solid-phase antigen - The 
absorbance recorded with 0,1 ml of 10 ug/m£ BCG as the solid-phase 
antigen was found to be optimum and hence was selected for the next 
step (Fig. 13; Table VII). 
Standardization of Inhibition assay using anti-BCG antibody -
A 1:1200 dilution of anti-BCG produced approximately 50% inhibition 
of interaction between the solid-phase (BCG) and the antibody-enzyme 
conjugate, i.e., when using a conjugate dilution of 1:2000 and a 
1:1200 dilution of anti-BCG, the absorbance value was decreased from 
1,5 (0,2ug/ml BCG) to 0,87 (20 p.g/ml BCG), a drop of approximately 
50%. The 1:1200 anti-BCG dilution was thus chosen to interact with 
0,1 ml of CSF in the inhibition assay. (Fig. 14). 
Sample and Conjugation Incubation - No significant differences were 
obtained after incubation for 1 hour at 45°C, 2-3 hours at 37°C or 
overnight at 4°C. 
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(b) ELISA results; 
-
CSF samples from patients with TBM could be clearly distinguished 
from those with bacterial and viral meningitis and from those of 
control groups on the basis of Inhibition ELISA results: The mean 
absorbance of the positive TBM samples was 0,658 +_ 0,043 as compared 
to 1,089 + 0,224 for normal CSF samples, 0,920 + 0,029 for bacterial 
CSF samples, and 0,903 _+ 0,104 for viral CSF samples. This difference 
in the means is statistically significant. Using the 'One Way 
Hypothesis of Analysis of Variance' it was found that the Variance 
ratio (F) was greater than both 1 and 5 points of variance-
ratio (F) distribution, i.e., when P < 0,01 and when P < 0,05, 
the variance between the mean absorbance values remained significant. 
(Table IX(a)). The distribution of absorbance values obtained when 
the various CSF samples were tested is illustrated in Fig. 16. The 
ELISA on TBM samples proved to be almost 100% sensitive and specific, 
i.e., no false-negative and only one false-positive result was 
recorded in the case of all 59 CSF samples tested. 
In the case of the pleural and ascitic fluids, the absorbance values 
obtained (Table VIII) showed a similarity in the case of tuberculous 
samples. The mean absorbance for pleural and ascitic fluid from 
tuberculous patients was significantly lower than that of the mean 
absorbance value for the control ascitic fluid samples. On application 
of the 'One Way Analysis of Variance' test this difference between the 
normal and tuberculous groups was confirmed (p < 0,05 and p < 0,01). 
(Table IX(b)). The distribution of the absorbance values obtained 
whilst testing the pleural and ascitic fluid samples is illustrated 
in Fig. 15. 
TABLE VII : RESULTS OF CHEQUERBOARD TITRATION USING BCG ANTIGEN AND REFERENCE SERA 
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The antigen dilutions on the left-hand side of the 
microtitre plate were reacted with each of the 
POSITIVE serum dilutions listed above. 
The antigen dilutions on the right-hand side of 
the micro-titre plate were reacted with each of 
the NEGATIVE serum dilutions listed above. 
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0,3 , 
Fig. 13 : Graph of absorbance versus antigen concentration 
for chequerboard titration with reference sera 
i r~ 
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Depiction of the yellow-coloured product 
(p-nitrophenol) produced by the enzymatic 
hydrolysis of p-nitrophenyl phosphate by 
alkaline phosphatase 
Fig. 12 : Absorbance vs Conjugate Dilution (Inhibition ELISA) 
Solid phase: BCG antigen in polystyrene tubes 
Conjugate : BCG antibody conjugated with alkaline phosphatase 
/jj 30 min , Conjugate 
" ^ Room T° Incubation 
- > 




























*After 30 minutes incubation at room temperature. 
An enzyme immuno-assay was carried out to determine 
the optimal working dilution of the conjugate. 
Polystyrene tubes coated with Human IgG were 
used to compare absorbance values obtained 
with various conjugate dilutions. An absorbance 
value of approximately 1,0 was chosen as the 
optimum absorbance value. 
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TABLE VI : VARIATIONS IN ABSORBANCE VALUES 
OBTAINED WITH VARIOUS MICROPLATES 
TYPE OF MICROPLATE 
NUNC FLAT-BOTTOMED PLATE 
>& 442404 
TITERTEK ACTIVATED PLATE 
j& 77-773-05 
DYNATECH REMOVASTRIP 
SYSTEMS OF IMMULON ® 
NUNC FLAT-BOTTOMED STRIPS 
MODULES F-16 =̂ft= 469914 
Mean absorbance 
+ S.D. 
1,159 + 0,047 
1,169 + 0,056 
1,194 + 0,049 
1 ,219 + 0,072 
An identical enzyme-immunoassay was carried out in all the wells 
in each of 4 different microtitre plates. The mean absorbance 
value per plate and the standard deviation for each plate was 
calculated. 
Fig. 14 : Inhibition of interaction between the solid phase (BCG) 
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TABLE VIII : RESULTS OF 'INHIBITION ELISA' 















Mean + S.D. 
1,089 + 0,224 
0,920 + 0,029 
0,658 + 0,043 
0,903 + 0,104 
Range 
1,486 - 0,934 
0,975 - 0,879 
0,742 - 0,601 
1,070 - 0,597 












Mean + S.D. 
0,791 +_ 0,091 
0,741 + 0,065 
0,966 + 0,055 
Range 
0,883 - 0,647 
0,883 - 0,647 
1,052 - 0,903 
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TABLE IX : ANALYSIS OF VARIANCE TABLES FOR INHIBITION ELISA RESULTS 


























































Fig. 15 : Distribution of absorbance values of pleural and ascitic fluid 























Distribution cf absorbance values ot CSF samples 
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The enzyme-linked immunosorbent assay (ELISA) for detection of myco-
bacterial antigens appeared to be reasonably sensitive. Sensitivity 
is defined as the number of cases the test calls positive, specificity 
as the fraction on non-cases the test calls negative. In order to 
evaluate the specificity of the assay, seven different types of 
patients were selected. ELISA tests on proven cases of TBM were 
carried out to get an estimate of false negative results. Incidence 
of false positivity was evaluated by tests on pleural, ascitic and 
CSF samples, normal and abnormal, but of non-tubercular aetiology. 
The specificity of the assay (98,3%) requires further investigation. 
The total number of 10 cases of TBM was too small to draw any 
conclusions about the validity of the assay in the clinical situation. 
However, the results obtained are favourable towards INHIBITION ELISA 
as a possible diagnostic procedure for TBM. Forty-eight samples of 
CSF definitely not from patients of TBM were non-reactive (25 samples 
were normal, 14 samples were from viral meningitis patients, and 10 
were from bacterial meningitis patients). Only one sample (from a 
patient with viral meningitis) reacted falsely. It is significant 
that the bacterial antigens present in the bacterial meningitis 
group of patients did not cross-react with mycobacterial antigens 
(p < 0.01). 
The INHIBITION ELISA has potential for improvement. The use of mono-
clonal antibodies raised against M. tuberculosis or antibodies against 
antigenic components exclusive to M.tuberculosis such as antigen 5 or 
6 may serve to increase the specificity of the assay. 
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(vi) Conclusion 
The inhibition assay was reactive for mycobacterial antigens in 
all ten patients who were clinically diagnosed as having TBM. Of 
the 84 patients studied, 49 proved to be of non-tuberculous 
aetiology and all but one were non-reactive for mycobacterial 
antigens in the ELISA test. The INHIBITION assay hence appears 
to be a promising approach for a definitive diagnosis of TBM. 
The assay may have potential in simplifying the diagnosis of abdominal 
and pleural tuberculosis. Fifteen pleural and ascitic fluid samples 
of tubercular aetiology were distinguishable from ten similar samples 
of non-tubercular aetiology. Further evaluation of the assay in the 
clinical situation is required before it may be adopted as a diagnostic 
aid for the detection of mycobacterial infections. 
3. Double Antibody Sandwich ELISA 
(i) Objectives 
(a) To determine whether the detection of mycobacterial antigens in 
the CSF of patients with TBM by double antibody sandwich ELISA 
is rapid and reliable. 
(b) To confirm the findings of Sada et al, who found the double 
antibody sandwich ELISA to be useful for the detection of 
soluble antigens of mycobacteria in CSF of patients with TBM. 
ELISA has been used in antigen detection of several infectious diseases 
and is a simple and rapid method. On the basis of a report by 
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(47) Sada et al, in 1983 that it was possible to detect mycobacterial 
antigens in CSF of patients with TBM it was decided that the 
reproducibility of Sada's assay would be investigated in the 
South African context. 
Before the ELISA could be performed on CSF samples, various 
preliminary investigations and techniques had to be performed. 
The enzyme-antibody conjugate was not available commercially 
and had to be prepared and tested before use. In addition, the 
acceptability of various microtitre plates was investigated; the 
selection of optimum amount of the solid-phase antibody and the 
suitability of various conjugate and sample incubation conditions 
was also investigated. 
(ii) Method 
(22) 
The method used was essentially that of Engvall and Perlmann 
(47) 
which had been adapted by Sada et al, for the detection of 
mycobacterial antigens. The assay had to be standardized prior 
to the testing of CSF samples. 
(iii) Results 
Working dilution of conjugate - Absorbance of approximately 1,0 
given by a 1:150 dilution of the conjugate after 90 minutes 
incubation at 45 C was considered optimum and was selected for 
the next step. 
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Selection of optimum amount of the solid-phase antibody - The 
absorbance recorded with 0,1 m£ of the anti-BCG diluted 1:800 as 
the solid-phase antibody was found to be optimum and was selected 
for the next step. 
ELISA technique - 100 u£ amounts of CSF samples from 20 normal 
and abnormal patients of non-tubercular aetiology were tested in 
order to evaluate the incidence of false-positivity. In addition, 
a row of positive standards consisting of commercial BCG solutions 
was included. A bright yellow colour (indicating a positive test) 
was found to have developed in all the wells, including those 
containing normal CSF. The entire assay was repeated (including 
the conjugation procedure and the standardization of the assay). 
Similar results (intense colour development) were recorded on 
repetition of the assay. 
(iv) Discussion 
The DOUBLE ANTIBODY SANDWICH ELISA for the detection of soluble 
antigens of mycobacteria in CSF did not appear to be either specific 
• • (47) 
or sensitive; contrary to reports by Sada et al. 
The optimal dilution of antibody selected to coat the solid-phase 
was identical to that determined by Sada et al, i.e., 1:800. The 
conjugate (prepared in a similar manner to that by Sada et al) was 
found to be active (activity was assayed by EIA), however, a more 
concentrated solution was used (1:150 as compared to 1:1000). 
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The incidence of false-positivity recorded was thought to be 
caused by non-specific binding of the antibody-enzyme conjugate 
to the solid-phase antibody. Various antigenic components 
present in CSF may have bound to the solid-phase antibody, and 
therefore also to the conjugate, hence causing intense colour 
development. These antigenic components, if identical or nearly 
identical to the correct mycobacterial antigens at the binding 
point of the anti-BCG, can be recognized by the anti-BCG. This 
reactivity towards incorrect antigen is therefore not a correct 
reactivity and is called cross-reactivity. 
The assay is based on the fact that M.bovis BCG and M. tuberculosis 
have the same surface antigens (as tested by reference antisera), 
thus anti-BCG is used in the assay as the solid-phase antibody. 
One way to improve the sensitivity and specificity of the test 
would be to use monoclonal antibodies raised against M. tuberculosis. 
Coates et al, have reported the production of murine monoclonal 
antibodies, using the hybridoma technique. These monoclonal 
antibodies are able to distinguish between strains of M.bovis 
and M. tuberculosis and even between certain strains of M.tuberculosis. 
Alternatively, antibodies raised against antigens 5 and 6 of 
• (13) 
M. tuberculosis by Daniel and Janicki which are specific 
for M. tuberculosis, if used as the solid-phase antibody, could 




The detection of soluble M.tuberculosis antigens in CSF of patients 
with TBM was not possible using the DOUBLE ANTIBODY SANDWICH ELISA 
of Sada et al. The false positivity recorded with 20 normal CSF 
samples made these indistinguishable from positive control BCG 
standards. The results obtained by Sada et al, were hence not 
reproducible even on duplication of the entire procedure. The 
specificity and sensitivity of the assay may be improved by 
using monoclonal antibodies or antibodies raised against 
antigens 5 and 6 which are specific for the M. tuberculosis 
bacillus as the solid-phase antigen. 
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TABLE X : OPTIMAL DILUTION OF CONJUGATE 







































*1 After 90 minute incubation at 45 C 
*2 After 30 minute incubation at room temperature. 
1,4 ., 
Fig. 17 : Absorbance vs Conjugate dilution 
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The values represent spectrophotometer readings (E405) 
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Fig. 18 : Graph of absorbance versus serum dilution for chequerboard 






TBM always causes an illness grave enough to require hospital 
admission. It is virtually impossible for a patient to recover 
spontaneously without treatment. The average duration of the 
disease from onset to death is only about 17 days if it goes 
undetected. Diagnosis of TBM is difficult in the early stages of 
the disease. The clinical picture presented is non-specific and 
onset is typically insidious. It has been established that the 
severity of the outcome of TBM (either death or neurological and 
intellectual impairment in the majority of cases) is linked to 
the stage of the disease at which diagnosis and chemotherapy is 
introduced. The earlier the diagnosis, the less severe the sequelae. 





° I II HI N/K 
Stages of Disease 
Fig. 19 : Outcome of TBM according to stage at diagnosis, 
(after Deeny, J.E., et al, 1985) 
Presently the diagnosis of TBM is made on the basis of past exposure 
to tuberculosis, clinical picture, positive Tuberculin skin test and 
CSF laboratory profile. The only definitive investigation is the 
identification of M.tuberculosis in CSF. However, the bacillus is 
only identified in a minority of cases and positive cultures have 
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been obtained from CSF samples with no apparent cellular content. 
Culture of the bacillus takes six to eight weeks and is only positive 
in a few patients (<10%). Other methods have been used in the 
diagnosis of TBM (radioactive bromide partition test; CSF ADA 
levels etc.) but though helpful, none have proven confirmatory 
for the disease. In addition, expensive and complicated equipment 
is required which is not always available in underdeveloped regions 
where the disease is most common. 
The use of ELISA as a rapid and simple method to detect antigens 
and antibodies raised against several infectious diseases has been 
established. Sada et al, reported the use of ELISA to detect 
mycobacterial antigens. This technique as well as the INHIBITION 
ELISA were evaluated in the detection of soluble mycobacterial antigens. 
The INHIBITION ELISA appeared to be reasonably sensitive. The 
sensitivity and specificity was almost 100% - no false negative and 
only one false positive result occurred among the CSF samples tested. 
It is realized that a total number of ten cases of TBM is too small 
to draw any definite conclusions on the specificity of the assay in 
the clinical situation. Many more samples need to be tested before 
the INHIBITION ELISA can be adopted as a diagnostic aid in TBM. 
The use of the INHIBITION ELISA to detect mycobacterial antigens 
has potential clinical application as an accurate test in the 
diagnosis of tuberculosis. The ELISA was shown to detect mycobacterial 
antigens in body fluids (pleural and ascitic) in human tuberculosis. 
On further evaluation, the INHIBITION ELISA may prove useful in 
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simplifying the diagnosis of human TB. Possibilities also exist 
for the detection of mycobacterial antigens in veterinary science. 
Many animals and much income is lost annually in South Africa as a 
result of mycobacterial infection of cattle. The INHIBITION ELISA 
may prove useful in diagnosing these infections. 
It is significant that the bacterial antigens in CSF samples did 
not cross-react with the mycobacterial antigens in the INHIBITION 
ELISA. Cross-reactions between polysaccharides of mycobacteria and 
other bacterial genera have been reported by several groups of 
researchers. It is doubtful whether sputum or urine samples from 
tuberculous patients could be used in the ELISA (INHIBITION). This 
is so because the antigens of mycobacteria are known to cross-react 
extensively with those of saprophytic mycobacteria, Nocardia, 
Corynebaateria and many other genera. Sputum and urine are known 
to have a large commensal population of bacteria which would 
undoubtedly cross-react in the INHIBITION ELISA, thus causing a 
loss in specificity of the assay. 
The INHIBITION ELISA for the diagnosis of TBM and human and bovine 
tuberculosis may be improved and made more specific if antibodies 
which are more specific than anti-BCG are used. Monoclonal anti-
bodies raised against M.tuberculosis or antibodies directed against 
antigens 5 and 6 which are specific for the bacillus may be used to 
improve the assay. This is also true for the DOUBLE ANTIBODY 
SANDWICH ASSAY. Alternatively, these specific antigens may be used 
to detect mycobacterial Ag's in CSF by simplifying the ELISA if 
latex is used as the solid-phase. If successful, this technique 
would prove useful to doctors in rural areas as a minimum of 
equipment would be required. 
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Unfortunately the normal CSF samples tested with the DOUBLE ANTIBODY 
SANDWICH ELISA were indistinguishable from positive control BCG 
solutions on the basis of colour. A uniform intense yellow-coloured 
product was formed in all wells tested, even on repetition of the 
entire assay procedure, including the conjugation process. This 
may be attributed to non-specific binding of the antibody-enzyme 
conjugate to the solid-phase antibody. Alternatively, antigenic 
components in the normal CSF may have become partially bound to 
the solid-phase antigen, and thus captured the conjugate, hence 
the coloured product. The solid-phase antibody may not be suitable 
for use in the assay but this is doubtful since Sada et al (1983) 
reported a measure of success with the same method and similar 
reagents. 
Unlike the Serum/CSF Bromide ratio, the BLOOD/CSF chloride ratio 
did not tend towards unity as a result of increased permeability 
of the blood-brain barrier in patients with TBM. The BLOOD/CSF 
chloride ratio was found to be raised by a similar quantity in 
all types of meningitis (bacterial, viral, and TBM). Hence the 
BLOOD/CSF chloride ratio is of negligible use in the differential 
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APPENDIX A 
LOWRY METHOD OF PROTEIN DETERMINATION 
Materials and Equipment 
(i) Protein to be measured 
(ii) Buffer in which protein is dissolved 
(iii) Standard protein (Albumin, bovine serum-BSA) 
(iv) 2% (w/v) copper sulphate, hydrated (5H„0) 
(v) 4% (w/v) sodium potassium tartrate 
(vi) 3% (w/v) sodium carbonate in 0,2 N sodium hydroxide 
(vii) Folin and Ciocalteu's phenol reagent 
(viii) Visible light spectrophotometer. 
Procedure 
1. Make a 1 mg/ml solution of the standard protein and calculate 
the exact concentration from its absorbance at 280 nm. 
1% 
For BSA, the extinction coefficient for E ° (th'e absorbance 
of a 10 mg/ml solution at 280 nm) is 6,7. 
2. Pipette an aliquot of the unknown solution containing 5-50 ug 
of protein, the same volume of the buffer blank, and 0, 2, 5, 
10, 20, 35 and 50 \i2 of the standard solution (the zero tube 
is the water blank) into separate tubes. 
3. Add water to bring the contents of each tube to the same volume 
(preferably < 200 u£). 
4. Mix 1 m£ of the copper sulphate solution and 1 m£ of the 
tartrate solution with 48 ml of freshly prepared carbonate 
solution. Add 1 ml of this to each tube, mix and incubate 
for 10 minutes at room temperature. 
5. Add 50 u£ of phenol reagent to each tube, mix again and 
incubate for 25 minutes. 
6. Mix again and 5 minutes later, read the absorbance of each 
tube at 640 nm, using water to blank the spectrophotometer. 
APPENDIX B 






















Tween 20 0,5 ml 
NaN3 0,2g 
BSA 10g 
Distilled water q.s. ad 1000 ml 
109 
TRIS BUFFER (pH 8,0) 
TRIS BUFFER (SIGMA ̂ T-1378) 6,05 g 
BSA 10 g 
NaN3 0,02 g 
Distilled water 1000 ml 
Substrate 
p-Nitrophenyl phosphate disodium salt 
C6H4NNa206P. 6H20 
MW 371,15 
Linkage which can be split enzymatically 
02N 
\ 
0 — P — 0 2Na 
® 
Reaction: 
p-nitrophenyl phosphate + H„0 AP -> p-nitrophenol + Pi 
The p-nitrophenol produced is measured spectrophotometrically at 405 nm. 
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Substrate Buffer (pH 9,8) 




Add a 1 mol/1 solution of HCl to give pH 9,8 
Distilled water q.s. 
PBS (pH 7,4) 
NaCl 8,0 g 
KC1 0,2 g 
KH2P04 0,2 g 
NaN 0,02 g 
Distilled water 1000 ml 
ad 
97 ml 
800 ml 
0,2 g 
1000 ml 
